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ABSTRACT
Imaging genetics is an emerging field dedicated to the study of genetic underpinnings
of brain structure and function. Over the last decade, brain imaging techniques such as
magnetic resonance imaging (MRI) have been increasingly applied to measure
morphometry, task-based function and connectivity in living brains. Meanwhile,
high-throughput genotyping employing genome-wide techniques has made it feasible to
sample the entire genome of a substantial number of individuals. While there is growing
interest in image-wide and genome-wide approaches which allow unbiased searches over
a large range of variants, one of the most challenging problems is the correction for the
huge number of statistical tests used in univariate models. In contrast, a reference-guided
multivariate approach shows specific advantage for simultaneously assessing many
v

variables for aggregate effects while leveraging prior information. It can improve the
robustness of the results compared to a fully blind approach.
In this dissertation we present a semi-blind multivariate approach, parallel
independent component analysis with reference (pICA-R), to better reveal relationships
between hidden factors of particular attributes. First, a consistency-based order estimation
approach is introduced to advance the application of ICA to genotype data. The pICA-R
approach is then presented, where independent components are extracted from two
modalities in parallel and inter-modality associations are subsequently optimized for pairs
of components. In particular, prior information is incorporated to elicit components of
particular interests, which helps identify factors carrying small amounts of variance in
large complex datasets. The pICA-R approach is further extended to accommodate
multiple references whose interrelationships are unknown, allowing the investigation of
functional influence on neurobiological traits of potentially related genetic variants
implicated in biology. Applied to a schizophrenia study, pICA-R reveals that a complex
genetic factor involving multiple pathways underlies schizophrenia-related gray matter
deficits in prefrontal and temporal regions. The extended multi-reference approach, when
employed to study alcohol dependence, delineates a complex genetic architecture, where
the CREB-BDNF pathway plays a key role in the genetic factor underlying a proportion
of variation in cue-elicited brain activations, which plays a role in phenotypic symptoms
of alcohol dependence. In summary, our work makes several important contributions to
advance the application of ICA to imaging genetics studies, which holds the promise to
improve our understating of genetics underlying brain structure and function in healthy
and disease.
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CHAPTER 1

INTRODUCTION

In this dissertation we demonstrate the extended application of independent
component analysis (ICA), a model for blind source separation, to the imaging genetics
field. A consistency-based order estimation approach is designed for improved robustness
and a semi-blind parallel ICA model is proposed to enable the analysis of large complex
multi-modal datasets. Applications to real experimental data are also presented.

1. 1

Imaging Genetics

Imaging genetics explores the functional impact of genetic variations on neurological
traits, making a valuable strategy for identifying biological mechanisms mediating the
vulnerability to diseases.
Over the last decade, brain imaging techniques such as magnetic resonance imaging
(MRI) (Giedd, 2004; Lawrie and Abukmeil, 1998; Paus et al., 2001) have been
increasingly applied to study living brains. MRI can be used to measure morphometry,
task-based function and structural and functional connectivity in the brain. Structural or
functional imaging biomarkers are believed to be closer to the underlying biological
mechanisms affected by genetic variants than behavioral or symptom-based measures
(Rasch et al., 2010; Rose and Donohoe, 2013; Turner et al., 2006). Consequently, there is
a growing interest in studying imaging measures. In the case of structural imaging,
measurements can be obtained in different ways, ranging from single region-of-interest
(ROI) methods, to image-wide approaches such as voxel based morphometry (VBM)
1
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(Ashburner and Friston, 2005) and surface-based measures such as FreeSurfer (Fischl and
Dale, 2000). In the case of functional imaging, blood-oxygen-level-dependent (BOLD)
functional MRI (fMRI) has been widely used for studying the neural basis of spontaneous
or task-related brain activities (Fox and Raichle, 2007; Logothetis, 2003).
High-throughput genotyping employing genome-wide techniques has made it feasible
to sample the entire genome of a substantial number of individuals (Oliphant et al., 2002;
Shen et al., 2005). Targeted candidate gene strategies examining a limited number of
genetic variations have been successfully applied to the investigation of illnesses such as
Fragile X syndrome (Lightbody and Reiss, 2009). Yet, the candidate gene approach is
less applicable when the genetic basis of a disease is very complex and less understood.
For instance, little success has been achieved in replicating evidence for causal genes in
schizophrenia (SZ) (Duan et al., 2010) using a candidate gene approach. In contrast,
recent work has lent support for a polygenic model (Gottesman and Shields, 1967;
Purcell et al., 2009b) of the disorder, where an aggregate of common genetic variants
were shown to collectively account for a substantial proportion of variation in risk.
Indeed, besides SZ, a variety of complex mental disorders, including bipolar disorder,
autism and addiction, are suggested as multifactorial and polygenic (Barnett and Smoller,
2009; Crabbe, 2002; Muhle et al., 2004). Given such evidence, an unbiased search of the
entire genome bears more potential to delineate the underlying genetic architecture for
complex disorders where a significant proportion of risk is likely ascribed to many
genetic variants, each presenting a small effect size and failing to reach genome-wide
significance individually.

2
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1. 2

Motivation

While there is growing interest in image-wide and genome-wide approaches which
allow unbiased searches over a large range of variants, novel mathematical and
computational methods are desired to optimally combine two modalities. One of the most
challenging problems is the correction for the huge number of statistical tests used in
univariate models. The correction for multiple comparisons makes it highly difficult to
identify a factor of small effect size with a practical sample size. In addition, univariate
approaches are not well-suited to identify weak effects across multiple variables.
For this reason, multivariate approaches show specific advantage for simultaneously
assessing many variables for an aggregate effect. In particular, ICA poses a promising
candidate for modeling the linearly additive effect from multiple variables in the case of
polygenicity. As a blind source separation approach, ICA tends to capture variants
covarying with a same pattern into one single component, such that the data is
decomposed into a linear combination of underlying components, whose associated
loadings reflect the individual variations. In this way, genetic variants presenting small
effect sizes on the same neurological or behavioral trait might be identified and the
aggregate effect can be assessed.

1. 3

Specific Aims

Aim 1: Application of regular ICA to genotype data
The first aim of this project is to advance the application of regular ICA to genotype
data. As a blind source separation approach, ICA has been widely used in signal and
3
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image processing (Comon, 1994; Hyvarinen et al., 2001). Meanwhile, to extend the
application to genotype data, a major challenge lies in the order selection. This is due to
the fact that genetic components in general accounting for small amounts of variance
embedded in the genome, making it difficult to separate true signals from the background.
To address this issue, an order selection approach is designed based on component
stability.
Aim 2: Parallel ICA with reference
When applied to high-dimensional complex datasets, ICA suffers the curse of
dimensionality. To address this issue, a semi-blind multivariate model, parallel ICA with
reference (pICA-R), is proposed, such that prior knowledge is incorporated to guide the
data decomposition and help elicit components related to particular attributes.
Specifically, a closeness measure is imposed to extract independent components
resembling the assigned reference. A formulization of the model is introduced in the
dissertation, where the closeness is measured with L2-norm Euclidian distance.
Aim 3: Parallel ICA with multiple references
A third aim is to extend pICA-R to accommodate multiple references for improved
robustness. To achieve this, the reference input is designed as a matrix, with each row (or
reference vector) representing a referential set spanning variants likely related while the
interrelationships between different referential sets are to be investigated. The
constrained component is dynamically selected for each referential set and multiple
referential sets can constrain the same component.

4
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Aim 4: Application of pICA-R to imaging genetics
The proposed approaches are applied to real experimental data to investigate the
genetic underpinnings of abnormalities in brain structure and function involved in mental
disorders. In this dissertation, we present results of schizophrenia (SZ) and alcoholism
studies.

1. 4

Overview of Dissertation

The dissertation will be organized as follows:
Chapter 2 backgrounds the conducted research. The basic MRI technique for
structural and functional brain imaging is explained. The concept of single nucleotide
polymorphism (SNP) and a commonly used genotyping technique are also introduced.
And a brief description is given to the principle and common implementations of ICA.
Chapter 3 introduces the consistency-based order estimation approach. The proposed
approach successfully captures the order range where ICA extracts relatively more
accurate components and loadings. We describe in detail the assumption and the
mathematical model. Simulation is then presented to show the performance of the
approach under different scenarios.
Chapter 4 introduces the pICA-R approach. The novel semi-blind multivariate model
incorporates a priori knowledge to elicit components of specific attributes and assesses
multiple variables for aggregate effects. A detailed description is given to the
mathematical model and implementation. The approach has then been evaluated with

5
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simulated fMRI and SNP data. The results demonstrate the robustness of the approach
and its applicability in real imaging genomics studies.
Chapter 5 introduces the extended parallel ICA with multiple references. When
provided with multiple referential sets whose interrelationships are unknown, the
extended approach successfully captures those associated with the same neurobiological
trait through dynamic constraints for individual referential sets. The concept and
formularization are described in detail. A comprehensive evaluation of the extended
approach with simulated fMRI and SNP data is also presented.
Chapter 6 presents the investigation on scanning platform induced confounding
effects in structural MRI (sMRI) studies. This is an issue difficult to avoid especially in
imaging genetics as aggregated datasets are commonly employed to improve the sample
size and statistical power. The initial exploration with a large sMRI dataset confirmed
significant scanning effects from magnetic field strength, head coils and scanning
sequences. A nonparametric correction was then designed and demonstrated with a
second dataset to flexibly isolate scanning effects and refine the true effect of interest.
Chapter 7 demonstrates an application of pICA-R to the investigation of SZ.
Voxelwise gray matter concentration data were analyzed in conjunction with
genome-wide SNP data. Guided by a referential set derived from a susceptibility gene
ANK3, pICA-R identified a significant sMRI-SNP association, revealing a complex
genetic component underlying the SZ-related gray matter concentration reduction in
frontal and temporal regions. The identified genetic component exhibited significant
enrichment for SZ-relevance when independently assessed with the Psychiatric Genomic
Consortium (PGC) data.
6
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Chapter 8 presents an application of parallel ICA with multiple references to the
investigation of alcohol dependence. Voxelwise cue-elicited brain activation data were
analyzed in conjunction with genome-wide SNP data. A number of referential sets were
derived from susceptibility genes implicated in previous studies. When assessed
simultaneously, three referential sets derived from the CREB-BDNF pathway were
identified as contributing to the same SNP component, which was significantly associated
with a brain network reflecting hyperactivation in precuneus, superior parietal lobule and
thalamus for more severe alcohol dependence. The identified genetic factor involved a
number of neural signaling and development pathways implicated in a previous
meta-analysis, confirming a complex and polygenic nature of the disorder.
Chapter 9 summarizes and concludes the project and provides some possibilities for
future work.

7
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2. 1

BACKGROUND

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a medical imaging technique developed to
study internal structures and functions of the body. MRI images atomic nuclei by
depicting their nuclear magnetic resonance properties and has a primary advantage over
other imaging techniques in that it provides very high spatial resolution. In addition, MRI
does not require ionizing radiation and yields good contrasts between different types of
soft tissues, making it especially suitable for imaging living human brains.
In principle, an MRI image is a map that depicts the spatial distribution of a specific
property of magnetized nuclear spins. This property might differ among tissues where the
nuclear spins reside, allowing the morphology to be captured. The property might vary
with the status of the body, which enables a dynamic imaging of responses to external
stimuli. For human bodies, owing to the abundance of water, MRI signals are generally
derived from the behavior of hydrogen atoms.
For a single hydrogen atom, the proton spins about itself due to thermal energy. This
spin motion generates an electric current, which will induce a magnetic moment when
situated within a magnetic field. Meanwhile, the spin also results in an angular
momentum as the proton has an odd-numbered atomic mass. Under normal conditions,
the spins are randomly oriented and the induced magnetization moments tend to cancel
with each other, leading to a very small net magnetization.

8
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When an external magnetic field is applied, the spinning proton will initiate a
gyroscopic motion, known as precession, where the spin axis rotates around a central
axis, as shown in Figure 2.1. The precession axis is aligned to the applied magnetic field
and can possibly take two states: parallel (low-energy state) or antiparallel (high-energy
state) to the magnetic field.

Figure 2.1: Precession.
The low-energy state is more stable and spins are more likely to assume this state
under normal conditions. Meanwhile, through absorbing electromagnetic energy, spins
can jump into the high-energy state, known as excitation. The corresponding resonance
frequency is defined as the Larmor frequency (ν), shown in (2.1). B0 denotes the applied
magnetic field and γ denotes the gyromagnetic ratio, which is the ratio of the magnetic
moment over the angular momentum vector. For hydrogen, the Larmor frequency is
within the radiofrequency (RF) band, around 42.58MHz/Tesla.
(2.1)

In the situation of receiving an excitation pulse, the precessing spins will be tipped
from the longitudinal direction towards the transverse plane perpendicular to the
precession axis. The net magnetization thus no longer aligns with B0, but exhibits an
9
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angle, known as the flip angle. When the excitation is turned off, the tipped precession
realigns back to the magnetic field, a phenomenon called relaxation. Figure 2.2 illustrates
two primary relaxations: longitudinal and transverse relaxation. During longitudinal
relaxation, excited spins return to the low-energy state, resulting in an increase of the
longitudinal magnetization. The emitted energy is absorbed by the lattice of nuclei, also
known as spin-lattice relaxation. The time constant associated with this recovery is called
T1 and the process is also called T1-recovery. During transverse relaxation, the spins
gradually lose phase coherence due to spin-spin interactions or field strength
inhomogeneity, resulting in a decrease of the transverse magnetization. T2 constant is
used to characterize the decay induced by spin-spin interaction, while the overall decay is
characterized by T2*.

Figure 2.2: Schematic illustration of spin relaxation. (a) longitudinal/T1 relaxation; (b)
transverse/T2 relaxation (Hashemi et al., 2003).
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The varying net magnetization can be detected by receiver coils and is a measurable
MR signal. To encode spatial information, a gradient magnetic field is introduced. In this
way, the magnetic field strength varies systematically over space, resulting in different
resonance frequencies. Thus a RF pulse can be applied to selectively excite a specific
slice, known as slice selection. After the longitudinal net magnetization of one slice is
tipped into the transvers plane, a frequency encoding and phase encoding gradient can be
further applied to acquire the k-space MR signals. Finally the MR images can be easily
reconstructed from the k-space signals using Fourier transform.
MRI can be versatilely configured to emphasize contrasts reflecting different tissue
characteristics. As shown in Figure 2.3a, the recovery of longitudinal magnetization
varies between tissues with different T1 constants. This allows different levels of
T1-contrast to be obtained through adjusting the repetition time (TR, time interval
between successive excitation pulses). T1-weighted images are the most commonly used
to study anatomical brain structures (sMRI), given a T1 constant of ~900ms for gray
matter (GM), ~600ms for white matter (WM) and 4200ms for cerebrospinal fluid (CSF).
On the other hand, T2-contrast reflects the difference in T2 constants among the tissues
and can be adjusted through the echo time (TE, time interval between the excitation and
data acquisition), as shown in Figure 2.3b. T2*-contrast is commonly used in BOLD
fMRI, where brain functions are approximated by the associated changes in blood flow.
The technique relies on the fact that when a brain region is in use or activated, the blood
oxygen level increases and this oxygenation increases the T2* constant. Thus the visibility
of blood vessels would reflect the regional brain activities in a T2*-contrast image.

11
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Figure 2.3: Schematic illustration of (a) T1- and (b) T2- contrasts.

2. 2

Single Nucleotide Polymorphism

DNA sequences may differ among members of a species at a single nucleotide, a type
of genetic variation known as single nucleotide polymorphism (SNP), as shown in Figure
2.4. The alternate forms of base pairs are called alleles, of which the more frequently
observed in one population is assigned as the major allele while the other as the minor
allele. SNPs are highly abundant across the whole genome, with an occurrence rate
estimated to be 1 out of every 300 bases for SNPs whose minor allele frequencies are
12
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higher than 1%, resulting in at least 10 million common SNPs out of 3 billion bases for
the human genome (Gibbs et al., 2003).

Figure 2.4: Illustration of a SNP with C/T polymorphism (use without permission from
Wikipedia).
SNPs fall into both coding and non-coding regions and have different consequences
at the phenotypic level. Polymorphisms in coding regions of genes may affect the
structures or functions of the encoded proteins, which further contribute to diseases. For
instance, The APOE (apolipoprotein E, chromosome 19) ε4 allele is a confirmed
susceptibility factor for late-onset Alzheimer’s disease (Farrer et al., 1997). On the other
hand, the majority of SNPs reside in non-coding regions. Although their direct impacts
on phenotypes are not known, these SNPs may still affect transcription factor binding,
messenger RNA degradation, etc.
Consequently, SNPs pose as promising markers to locate genes that predispose
individuals to diseases. The investigation can be performed through genotyping a
13
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collection of SNPs to identify those exhibiting allele frequency differences between
control and patient groups. The number of SNPs that needs to be genotyped depends on
the disease to be investigated. While genotyping a few SNPs in candidate genes may be
adequate for monogenic disorders, explorations of complex and heterogeneous diseases
whose genetic structures are less understood favor whole-genome SNP mapping. This is
only made available upon the advance of the high-throughput genotyping technology.
One of the commonly used genotyping platforms is the BeadArray (Oliphant et al.,
2002; Shen et al., 2005) from Illumina, based on which a whole-genome genotyping
assay (Infinium) is developed (Gunderson et al., 2006). In the BeadArray technology,
each array is assembled on an optical fiber bundle fused into a hexagonally packed
matrix, as shown in Figure 2.5a. The fiber bundle is then exposed to the bead pool, such
that the individual beads with distinct oligonucleotide probes can be assembled into the
array. Figure 2.5b illustrates a scanning electron micrograph of an assembled array.
Finally the arrays are arranged into a matrix to increase throughput.
The Infinium SNP genotyping assay consists of four steps: amplification,
hybridization, SNP scoring and detection. Figure 2.6 illustrates the flowchart. Starting
from a sample of 750ng, the DNA is whole-genome amplified 1000-2000× in an
unbiased isothermal reaction (step 1-2). The amplified DNA then undergoes
fragmentation, isopropanol precipitation and resuspension (step 3-4). Subsequently, the
prepared sample is mounted to the BeadArray, where the designed probes capture the
target loci through hybridization (step 5-6). Finally, the products are fluorescently stained
(step 7), and the fluorescence intensities can be detected through BeadArray Reader (step
8). The data will then be analyzed to generate genotype calling using automated software.
14
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Figure 2.5: Assembly of an optical fiber array; (A) An etched fiber optic bundle is
exposed to the bead pool, allowing individual beads to assemble into the microwells at
the bundle’s end; (B) Scanning electron micrograph of an assembled array containing
3-μm diameter silica beads ((Oliphant et al., 2002), Courtesy of Todd Dickinson).

Figure 2.6: Illumina Infinium assay protocol (Gunderson et al., 2006).
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2. 3

Independent Component Analysis

Independent component analysis (ICA) is a blind source separation method which has
been widely used in many fields such as signal and image processing (Comon, 1994;
Hyvarinen et al., 2001). In an ICA model, the observed data are treated as a linear
combination of unknown independent sources, and the aim is to decompose the observed
data and extract the sources through maximizing the independence among them. ICA
becomes a popular technique for biomedical signal analysis, given that the measured
signals are commonly mixtures of various underlying sources including both features of
interest and noise/background signals.
A typical ICA model is shown below in (2.2), where the observed data are formed by
a linear combination of the underlying sources, which are assumed to be not observable,
statistically independent and non-Gaussian. X denotes the observed data with the
dimension of sample (M) × feature (N) (typically, N ≥ M). S denotes the unknown source
matrix, where each row represents an independent component. L is the number of
independent components (ICs). A denotes the unknown mixing matrix, with each column
representing the loading coefficients associated with one independent component.

[

]

[

]

[ ]
(2.2)

In ICA, the underlying sources are extracted through estimating an unmixing matrix
W such that Y is a good approximation to S, as shown in (2.2). The estimation of the
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unmixing matrix W is usually an iterative process where W is updated based on a
specific objective function to optimize the independence among components. Several
ICA algorithms have been implemented for the estimation of W where various
independence metrics are employed, including Infomax, fastICA, JADE, EVD, and
AMUSE (Bell and Sejnowski, 1995a; Cardoso and Soloumiac, 1993; Georgiev and
Cichocki, 2001; Hyvarinen and Oja, 1997; Tong et al., 1990).
Among these ICA algorithms, Infomax (Amari, 1998; Bell and Sejnowski, 1995a) has
been suggested as yielding reliable results for brain imaging data (Correa et al., 2007).
More recently, the application of ICA was extended to genotype data (Chen et al., 2012c;
Dawy et al., 2005; Liu et al., 2009) and showed great promise due to its multivariate
nature, which helped identify components representing combined effects from multiple
SNPs and associated with a given phenotype.
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3. 1

CONSISTENCY-BASED ICA ORDER SELECTION

Introduction

A commonly used ICA algorithms is Infomax (Amari, 1998; Bell and Sejnowski,
1995a), which has been suggested as yielding reliable results for brain imaging data
(Correa et al., 2007). Infomax requires selecting the order, or the component number,
before data decomposition. Information-theoretic criteria, such as Akaike information
criterion (AIC) and minimal description length (MDL), have been employed (Akaike,
1973; Calhoun et al., 2001; Rissanen, 1978; Wax and Kailath, 1985) to solve this
problem. In particular, a modified MDL criterion was specifically developed for ICA
applied to functional magnetic resonance imaging (fMRI) data (Li et al., 2007).
The order selection is much more challenging for genotype data compared with MRI
data, since in general genetic components account for small amounts of variance
embedded in the genome (except for those accounting for the population structure),
making it difficult to separate signal of interest from non-related information. In addition,
a principal component analysis (PCA) data reduction is usually applied before
Infomax-ICA to select out the same number of principal components accounting for the
most variance of the data. This PCA reduction obviously does not guarantee the inclusion
of information related to a genetic component carrying small variance. While using
variance to identify the true component number works less effectively for genotype data,
we observed that using consistency leads to relatively more accurate results. Thus,
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instead of using the information-theoretic criteria, we propose to select the order based on
consistency for genotype data.

3. 2

Method

The proposed order selection procedure consists of three steps: ICA runs, consistency
map construction and order selection.
ICA Runs
We apply Infomax-ICA to a given dataset XM×N with different orders (denoted as l),
as shown in (3.1). Sl and Al respectively represent the components and loadings extracted
by ICA with an order of l. The maximal tested order is denoted as L.
(

)

(3.1)

Consistency Map Construction
Given the ICA results from different tested orders, two consistency maps are
constructed, one for components (CS) and the other for loadings (CA). The consistency
evaluates the overall components’ or loadings’ similarity measured by correlations within
a range of tested orders. Specifically, for the kth component extracted in an ICA run with
order l (denoted as Sl(k)), we identify the most similar component extracted in the
following ICA run with order l+1 (denoted as Sl+1(k’)), and then record the absolute
value of their correlation as an element CS(k,l) in the component consistency map, as
shown in (3.2). This procedure is repeated for each component extracted in each ICA run,
and thus the component consistency map, CS, is constructed as the upper triangular part
of an L×L matrix. In a similar way, we construct the loading consistency map CA. Within
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the consistency matrices CS and CA, each column of the upper triangle reflects the
overall consistency across all components or loadings extracted in one ICA run, while
each row depicts the consistency evolution of one specific component or one set of
loadings across all the tested orders.
(

)

[

( ( )

( ))]

(3.2)

Order Selection
In this step, we locate the desired order which leads to, relatively speaking, the most
accurate components and loadings. Three strategies can be applied: overall consistency,
reference-blind consistency, and reference-specific consistency.
A.

Selection based on the overall consistency (overall)
Within the component consistency map, we focus on its upper triangle and calculate

the mean of each column to obtain the overall component consistency CSova for each
tested order n, as shown in (3.3). It is expected that the overall consistency remains stable
with low orders and starts to decrease quickly when the increasing order results in a
components over-splitting situation. Thus, the turning point provides a good guidance on
the order selection. To avoid catching local oscillations, we search for a component order
range, RS, covering 10 consecutive tested orders, where the overall consistency exhibits
the largest descending gradient (G). The above procedure is repeated for the loading
consistency map and results in an order range RA. Finally, to balance both component and
loading consistencies, the median value of the overlapped range between RS and RA is
selected as the final order, denoted as lsel.
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Selection based on the consistency of a reference
Given a component of interest, Sr, as a reference, we select out from each ICA run

one counterpart component Scl that exhibits the most similar pattern to the reference.
Then to evaluate the reference’s consistency across tested orders, we apply a sliding
window covering 10 consecutive orders and calculate the overall consistency CSc
(average of all pairwise correlations) among counterpart components within that window,
as shown in (3.4). To avoid overfitting, among the windows exhibiting relatively high
consistencies (>CSc,th, chosen empirically), we select the leftmost to be the component
order range, denoted as RS. The above procedure is also repeated for the loadings,
resulting in the order range RA. Finally, to balance component and loading consistencies,
the median value of the overlapped range between RS and RA is selected as the final order
lsel. Depending on the purpose of the study, the reference selection can be guided by the
consistency map or phenotypical information, as described below:
( ̃)

{

(

[
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(
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)]}
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}

)

(3.4)
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Reference selected based on the consistency map (reference-blind): In the consistency
map, a segment in a single row exhibiting consecutively high correlations indicates a high
regional stability. The corresponding component is likely to be true and can serve as a
good reference.
Reference selected based on phenotypical information (reference-specific): The
selection of reference can also be guided by phenotypical information such as diagnoses
labels. For instance, in a schizophrenia study, we can select a component whose loadings
differentiate patients from controls as a reference.

3. 3

Simulation

We simulated a primary SNP dataset consisting of 200 samples and 5,000 SNP loci. 8
components were simulated using PLink (Purcell et al., 2007b), each involving 150
causal loci and a different case-control pattern. The causal loci exhibited different levels
of effect sizes, ranging from 1.77 to 18.86 with a median of 2.20. Furthermore, we
investigated the robustness of the procedure under different conditions, including effect
size of causal loci, number of samples, number of SNP loci and number of true
components.
ICA results derived from different orders were compared with the ground truth, and
the average accuracies were calculated as a function of the tested order. Specifically, the
component accuracy was evaluated by sensitivity, which is the ratio of correctly
identified causal loci over the known true loci. The loading accuracy was reported as the
absolute value of the correlation between the simulated case-control pattern and the
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extracted loadings. Based on the resulting accuracy, we examined whether the selected
order would lead to the optimal results.
In the primary test, we performed ICA runs with orders ranging from 2 to 100 and
then constructed the component and loading consistency maps, as shown in Figure 3.1,
where the color map indicates the strength of correlation. All three selection strategies
were tested. Using the overall consistency, the order was selected to be 19. Using the 8 th
component extracted with the order 17 as a reference (reference-blind), the order was
selected to be 18. Using the case-control pattern of the first simulated component as a
reference (reference-specific), the order was selected to be 21. The selected orders are
marked in Figure 3.1 and 3.2, where Figure 3.1 shows the positions and consistency
values of the selected orders in the two consistency maps, and Figure 3.2 provides a
summary of the performance evaluation across tested orders, indicating that the selected
orders lead to the optimal results.

3. 4

Results

The performances of the proposed procedure on datasets with different conditions are
summarized in Figure 3.3-3.5, where the selected orders are marked and compared with
other tested orders in terms of the resulting accuracies. It can be seen that we are mainly
identifying the leftmost sliding window exhibiting an optimal accuracy. In general, the
selected orders lead to relatively accurate components and loadings regardless of the ICA
performances.
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Figure 3.1: Component and loading consistency maps.

Figure 3.2: Performance evaluation of the primary test (200 samples, 5K SNP loci, 8 true
components, median effect size of 2.20).
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Figure 3.3: Performance evaluations on datasets with causal loci of different effect sizes
(200 samples, 5K SNP loci, 8 true components). Black and gray lines represent
component and loading accuracies respectively.

Figure 3.4: Performance evaluations on datasets with different sample sizes (5K SNP
loci, 8 true components, median effect size of 1.99). Black and gray lines represent
component and loading accuracies respectively.

Figure 3.5: Performance evaluations on datasets with different numbers of SNP loci (200
samples, 8 true components, median effect size of 2.04). Black and gray lines represent
component and loading accuracies respectively.
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Figure 3.6: Performance evaluations on datasets with different numbers of true
components (200 samples, 5K SNP loci, median effect size of 1.95). Black and gray lines
represent component and loading accuracies respectively.

3. 5

Discussion

The proposed order selection procedure employs consistency as a criterion to locate
the optimal order that results in relatively accurate components and loadings. Given its
robustness, we expect that ICA can consistently extract a true component within a range
of varying orders. This consistent region can be captured with different strategies, either
through evaluating the overall consistency across all components or evaluating the
consistency of a specific component across different orders, which can be selected based
on regional stability or phenotypical information. Simulations demonstrate robust
performances of all three strategies under different conditions.
Effect size of causal loci, number of samples and number of SNP loci: These varying
conditions result in components accounting for different amounts of variance of the data.
With a larger effect size, more samples or less input SNP loci, the simulated components
account for more variance of the data than those with a smaller effect size, less samples
or more input loci. When the components carry an adequate amount of variance, they can
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be accurately identified by ICA. In cases where ICA performs well, the order selection
procedure accurately pinpoints the optimal order providing the best results. In cases
where components are extracted with low accuracies, the proposed procedure still
captures the range where relatively accurate components and loadings can be obtained, as
shown in Figure 3.3-3.5.
Number of true components: We also simulated datasets with different numbers of
true components, ranging from 2 to 14. Figure 3.6 summarizes the performance on these
datasets. Overall, the proposed procedure exhibits robust performance where the selected
order consistently leads to reasonable results regardless of varying numbers of true
components. In addition, this evaluation clearly shows that, when a genetic component
accounts for a small amount of variance, a true component number does not guarantee
optimal results, since the component may be neglected in the PCA reduction applied
before Infomax-ICA.
Among the three order selection strategies, the “overall” and the “reference-blind”
methods are completely data-driven, while the “reference-specific” method involves
phenotypical information. To investigate whether the selection of phenotypical
information would affect the performance of the “reference-specific” method, we
simulated components with different case-control patterns, yet always used the pattern of
the first component to guide the reference selection. The simulation results indicate that
the selected orders result in optimal average accuracies of all components and loadings
regardless of the choice of phenotype. Thus we conclude that the reference selection can
be guided by any phenotypical information and the performance of the procedure is not
sensitive to this selection.
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In summary, we design a procedure to select the ICA order based on consistency. The
goal is to locate an order which allows ICA to extract relatively accurate, consistent
components and loadings, while the components and background signal carry comparable
variations. Three strategies have been implemented based on Infomax-ICA to achieve
this goal. Simulation results indicate robust performances of all three strategies under
different conditions and it is noteworthy that the procedure is able to select a reasonable
order even when ICA operates less efficiently. While it awaits further evaluation with
different ICA algorithms, we believe that there will be many applications for this
procedure, not limited to genotype data, but any data with very low signal-to-noise ratio.
Although the procedure proposed here is not mathematically ‘hard’ or ‘novel’, it will
bring in great practical benefit for many researches.
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PARALLEL

INDEPENDENT

COMPONENT

ANALYSIS WITH REFERENCE

4. 1

Introduction

Novel mathematical and computational methods are desired in imaging genetics to
optimally combine the image-wide and genome-wide approaches which allow unbiased
searches over a large range of variants. One of the most challenging problems is the
correction for the huge number of statistical tests in univariate models. The correction
makes it highly difficult to identify a factor of small effect size with a practical sample
size. In addition, univariate approaches are not well-suited to identify weak effects across
multiple variables. For this reason, multivariate approaches show specific advantage for
simultaneously assessing many variables for an aggregate effect. To better identify
aggregate effects across many variables, a number of models have been derived,
including principal component regression (PCReg) (Wang and Abbott, 2008), sparse
reduced-rank regression (sRRR) (Vounou et al., 2010) and parallel independent
component analysis (pICA) (Liu et al., 2009).
PCReg, sRRR, and pICA are designed to deal with datasets of high dimensionality
and yield interpretable results. However these approaches are not able to take prior
information into account. Such information can be useful to enable a guided yet flexible
approach and can improve the robustness of the results compared to a fully blind
approach. For instance, some genes known to participate in a biological pathway critical
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to a disease may help identify a set of genes contributing in a coordinated way to a larger
network. As observed in pilot studies, incorporation of prior information may be
especially helpful in analyzing genomic data, where a component usually accounts for a
small amount of variance in the data and is more difficult to identify (Chen et al., 2012c;
Liu et al., 2012). Thus, we propose parallel independent component analysis with
reference (pICA-R), which extends pICA to incorporate prior information to provide a
reference to guide analyses. While pICA is designed based on regular (blind) ICA to
enhance correlation between two modalities, pICA-R further takes advantage of a priori
knowledge to guide the analysis and pinpoint a particular component of interest
embedded in a large complex dataset. In this chapter, we compare pICA-R with other
multivariate models through simulated data and evaluate the models under several
scenarios.

4. 2

Method

Parallel independent component analysis with reference (pICA-R) is formulated by
incorporating a reference constraint into parallel independent component analysis (pICA)
(Liu et al., 2009) to guide the component extraction towards a priori knowledge. Typical
pICA builds on regular infomax (Amari et al., 1996; Bell and Sejnowski, 1995b) to
extract independent components in parallel for each modality, followed by a conditional
enhancement of the inter-modality correlations. In comparison, pICA-R imposes an
additional constraint upon the infomax framework to minimize the distance between a
certain component and the reference. The mathematical model is shown below, and
Figure 4.1 illustrates the flow of the approach.
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Given a dataset X with dimension of sample (i.e., subjects) × feature (i.e., voxels
[d=1], SNPs [d=2]), (4.1) illustrates the mathematical model of data decomposition,
where
(4.1)
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Figure 4.1: Flow chart of pICA-R. W1 and W2 denote the unmixing matrices of the two
modalities, respectively. F1, F2 and F3 represent the objective functions based on which
unmixing matrices are updated.
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the observed dataset X is decomposed into a linear combination of the underlying
independent components, or sources. S is the component matrix, A is the loading or
mixing matrix (estimated as the pseudo inverse of W), W is the unmixing matrix, and the
subscript d runs from 1 to 2, denoting the data modality. Specifically, pICA-R iteratively
solves the unmixing matrices W1 and W2 simultaneously for the two modalities,
gradually maximizing the objective functions F1, F2 and F3 in the manner described in
Figure 4.1. In particular, F1 is the objective function of the regular infomax (Bell and
Sejnowski, 1995b) for modality 1, where independence among components is achieved
by maximizing the entropy (H), as shown in (4.2). fy(Y) is the probability density
function of Y and W0 is the bias vector. In contrast, F2 is the objective function for
modality 2, where an additional closeness metric is imposed to extract maximally
independent components, one of which also closely resembles the reference r. The
inter-modality correlation function F3 shown in (4.3) is designed to maximize the
correlations computed over the columns of the loading matrices A1 and A2, capturing
connections between pairs of inter-modality components.
pICA-R incorporates an additional constraint to the unmixing matrix of modality 2
(W2), detaching itself from regular blind pICA. The objective function F2 is shown in
(4.2) and Figure 4.2 illustrates how the constraint is applied. In this application modality
2 is the genomic data. The reference r is a binary vector with the same number of loci as
the genomic data, where the selected reference loci are set to “1” and the rest are “0”s.
This binary reference effectively serves as a mask such that the closeness between the
component and reference vector is measured on the reference loci only. This design
considers that for a given reference a group of loci are presumably of interest and set to 1,
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Figure 4.2: Illustration of the applied distance constraint: (a) the underlying component
with highlighted causal loci (black region); (b) the generated reference, where r is the
reference vector with selected reference loci set to 1 (gray region) and other loci set to 0.
r̃ denotes a subvector consisting of all the reference loci; (c) the closeness is optimized
specifically for the selected reference loci of one component. W2 is the unmixing matrix
of modality 2, X2 is the data matrix and S2 is the component matrix. S̃ i denotes a
subvector of S2i (the ith row of S2), W2i denotes the ith row of W2 and ̃ denotes a
submatrix of X2.
however status of the remaining loci is to-be-determined instead of not interesting.
Therefore, we choose to optimize the closeness specifically for the selected reference loci
while allowing the remaining loci to show their own importance driven by data. This is
equivalent to minimizing ‖| ̃ |

̃‖ in F2, where ̃ denotes a subvector of r, ̃

denotes a subvector of S2k (the kth row of S2), W2k denotes the kth row of W2 and ̃
denotes a submatrix of X2, as illustrated in Figure 4.2. ||·||2 represents the L2-norm
Euclidian distance, and λ is a weighting parameter. It should be noted that we apply the
constraint only to one modality in this work, which provides a simple proof-of-concept
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and also fits the proposed application in imaging genetics. The constraint can be extended
to both modalities if necessary.
With the distance measure incorporated as an additional metric, the estimation of the
unmixing matrix W2 turns into a multi-objective optimization problem. It is well
understood that objective functions of individual objectives can be linearly weighted and
combined into a single aggregate objective function (F2), resulting in a less-complex
problem. And by choosing different values for the weighting parameter λ, we can explore
different points of the Pareto front (Klamroth and Tind, 2007), which justifies a strategy
of choosing the weight via simulation. In addition, we have adopted several strategies to
avoid overfitting. First, the constrained component (i.e., S2k in F2) is selected
dynamically based on the data. Specifically, in each iteration, we examine the distances
between the reference and all the components, and then select only the closest component
to be constrained. Second, to avoid over-emphasizing the distance metric, we adaptively
adjust the constraint weight λ. Starting with a heuristic weight, we monitor the overall
independence (log|det(W2)|) and the distance measure after each iteration, then adjust λ
accordingly to ensure the balance between the two objectives in the objective function.
The three objective functions (F1, F2 and F3) are optimized using gradient
maximization. Specifically, for F1 and F2, W1 and W2 are updated by the natural gradient
learning rule (Amari, 1998), and for F3, A1 and A2 are updated by the steepest descent
learning rule (Liu et al., 2009), as shown in Equations (4.4)-(4.6). α1, α2, αc1 and αc2
denote the leaning rates.
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Simulation

The proposed pICA-R approach was evaluated using simulated functional MRI
(fMRI) and SNP data for its capability to extract factors of interest, particularly in the
genetic modality. The fMRI data consisted of 200 samples (i.e., subjects) and 10K
voxels. Eight non-overlapping brain networks were simulated using the SimTB toolbox
((Erhardt et al., 2011), http://mialab.mrn.org/software). The SNP data were simulated to
investigate the performances of pICA-R when components accounted for different
amounts of variance in the data, which was achieved through adjusting sample-to-SNP
ratios, causal loci ratios, and effect sizes of causal loci. The sample-to-SNP ratio
compared the sample size (or number of subjects) with the total number of SNP loci (or
SNP dimensionality); the causal loci ratio compared the number of causal loci with the
SNP dimensionality; the effect size of causal loci was measured by percentage of
variance explained in disease status. Specifically, the SNP data consisted of 200
simulated samples (subjects), each with equal SNP dimensionality, which ranged from
10K to 500K. Eight non-overlapping SNP components were simulated using PLink
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(Purcell et al., 2007a), each involving 150 causal loci associated with a randomly
generated case-control pattern. The resulting sample-to-SNP ratio ranged from 0.02
(200/10K) to 4.00×10-4 (200/500K), and the causal loci ratio ranged from 0.015
(150/10K) to 3.00×10-4 (150/500K). The effect size of individual causal loci ranged from
0.003 to 0.21. None of the SNP components shared common causal loci. No high linkage
disequilibrium (LD) was observed among causal loci (maximum correlation < 0.39). We
further designed a mixing matrix for the fMRI data where randomly selected columns
were correlated to particular case-control patterns of the SNP components. The simulated
brain networks were then combined into one fMRI observation matrix through this
mixing matrix. Random Gaussian noise was superimposed afterwards. We did not adjust
the number of components in the simulations as the ability to recover the independent
hidden factors is not significantly affected by how many components are embedded,
provided that the number of components can be correctly approximated. We used
second-level (subject × feature) fMRI data in this simulation, however we would expect
comparable performances when pICA-R is applied to structural grey matter images,
given that both are feature-based maps and structure-function associations have been
observed at the feature level in an ICA framework (Calhoun et al., 2006; Segall et al.,
2012).
We then applied pICA-R to the simulated datasets and compared its performance with
those of ICA (regular infomax), ICA with reference (ICA-R) (Lin et al., 2010) and pICA.
Default settings were used for infomax, ICA-R and pICA. Since infomax, pICA and
pICA-R require selection of the component number, we set this to 8, the true component
number for the simulated data, for the fMRI modality in all tests. For the SNP modality,
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due to different data properties, the true component number may not yield reliable results
(Chen et al., 2012b). Therefore, in the tests with infomax and pICA, we examined
component numbers ranging from 5 to 50 (in steps of 5), and selected the one yielding
optimal results. The number of components was selected to be 50 in all pICA-R tests,
given our observation that the proposed pICA-R tends to be robust to over-estimation.
The performance was evaluated based on accuracies of the genetic components and
loadings, as well as the inter-modality connections. The SNP component accuracy was
assessed by a sensitivity measure, the ratio of correctly identified causal loci (among the
top 150 loci) to the built-in true causal loci. The genetic loading accuracy was reported as
the absolute value of the correlation between the simulated case-control pattern and the
extracted loadings. We also calculated the correlations between loadings of the two
components (SNP and fMRI) that most resembled the ground truth of the two modalities,
respectively, to assess the accuracy of the inter-modality connections.
Particularly, for the two semi-blind methods (pICA-R and ICA-R), we investigated
how their performances would be affected by the reference accuracies (ratio of true
causal loci in the reference, as illustrated in Figure 4.2). Previous work indicated that a
20-loci reference of accuracy 1 was required for ICA-R to reliably extract factors of
interest when the sample-to-SNP ratio was 0.02 (Liu et al., 2012). Guided by this, we first
tested a reference of accuracy 1, spanning 20 randomly selected true causal loci. We then
tested a 40-loci reference of accuracy 0.5, primarily to investigate how the performances
would be affected by adding random loci. Then accuracies were adjusted from 0.1 to 0.5
for the 40-loci references to investigate the influence. The performance was evaluated in
terms of sensitivity (as described above) and reference-imposed false discovery rate
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(FDR), which was to assess the overfitting by evaluating how many random referential
loci were falsely elevated as causal.

4. 4

Results

Figure 4.3: Performance comparisons among pICA-R, ICA (infomax), ICA-R and pICA:
(a) on simulated datasets with different effect sizes when the sample-to-SNP ratio was
controlled at 0.02 and causal loci ratio at 0.015; (b) on simulated datasets with SNP
dimensionality ranging from 10K to 500K, resulting in sample-to-SNP ratios ranging
from 0.02 to 4×10-4 and causal loci ratios from 0.015 to 3×10-4, the median effect sizes
were 0.057, 0.055, 0.050 and 0.050 respectively. For pICA-R and ICA-R, results were
obtained with a 20-loci reference of accuracy 1. The error bars reflect mean ± SD based
on 100 runs.
As expected, fMRI components were accurately identified (component and loading
accuracies higher than 0.9) in all tests, given that each component carried a considerable
amount of variance in the data. Regarding the SNP modality, with a 20-loci reference of
accuracy 1, pICA-R exhibited consistently better performance than the other algorithms
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in identifying SNP components with different levels of sample-to-SNP ratio, causal loci
ratio and effect size. Figure 4.3a and 4.3b summarize the simulation results, where the
error bar reflects mean ± SD based on 100 runs. It can be seen that accuracies of SNP
components, associated loadings and connections between SNP and fMRI measured by
sensitivity or correlation were all improved compared with infomax, ICA-R and pICA.
Also it is noted that pICA-R was able to identify the component with a sensitivity above
0.5 given a median effect size as low as 0.024 while the sample-to-SNP ratio was
controlled at 0.02 and the causal loci ratio at 0.015. While the median effect size was
controlled around 0.05, pICA-R in general exhibited robust performances within the
tested ranges of sample-to-SNP ratio and causal loci ratio. We also conducted a
simulation at the low sample-to-SNP ratio (200/500K) with an increased causal loci ratio
(1000/500K), a scenario similar to real data SZ application, and found that pICA-R
exhibited a comparable sensitivity (0.53) using a 20-loci reference of accuracy 1 (not
shown). Therefore, we assume that a reference spanning at least 20 true causal loci is
suitable for the real data application provided that the causal loci ratio is above 3.00×10-4.
The reference accuracy is crucial for identifying the correct component, as illustrated
in Figure 4.4. As expected, pICA-R showed increased sensitivities with references of
higher accuracies. It is also noted that a 40-loci reference of accuracy 0.5 yielded a
sensitivity around 0.5, comparable to that obtained with a 20-loci reference of accuracy 1.
Most importantly, the results indicated that when the sample-to-SNP ratio was lower than
0.004 (200/50K) and the causal loci ratio lower than 0.003 (150/50K), pICA-R started to
benefit in sensitivity compared to ICA and pICA with a reference accuracy as low as 0.2.
In contrast to sensitivity, the performance in reference-imposed FDR was less affected by
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the reference accuracy and remained below 0.05. Overall, pICA-R exhibited
improvements in both sensitivity and reference-imposed FDR compared to ICA-R.

Figure 4.4: Performance comparisons between pICA-R and ICA-R, with 40-loci
references of different accuracies: (a) on simulated datasets with different effect sizes
when the sample-to-SNP ratio was controlled at 0.02 and causal loci ratio at 0.015; (b) on
simulated datasets with SNP dimensionality ranging from 10K to 500K, resulting in
sample-to-SNP ratios ranging from 0.02 to 4×10-4 and causal loci ratios from 0.015 to
3×10-4, the median effect sizes were 0.057, 0.055, 0.050 and 0.050 respectively. The solid
and dotted lines reflect results of pICA-R and ICA-R, respectively.

4. 5

Discussion

The simulation results demonstrate that the approach helps capture factors of interest
more accurately. As illustrated in Figure 4.3a and 4.3b, pICA-R show consistently better
results for component accuracy, component loadings and inter-modality link compared to
regular ICA, ICA-R and pICA, and the improvement becomes more pronounced with
lower sample-to-SNP ratio and causal loci ratio, or smaller effect size. It can be seen that
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the proposed approach yields a sensitivity above 0.5 at a low sample-to-SNP ratio of
4.00×10-4 (200/500K) and a causal loci ratio of 3.00×10-4 (150/500K), while the median
effect size is around 0.05. This observation encourages the application of pICA-R to
genomic data with comparable sample-to-SNP and causal loci ratios, where a million or
so loci may be involved given an increased yet affordable sample size and hundreds of
causal loci.
On the other hand, it needs to be emphasized that reference accuracy plays an
important role in the performance of pICA-R. As clearly shown in Figure 4.4, when
random loci are incorrectly selected as references, pICA-R exhibits reduced sensitivity.
However, at relatively low sample-to-SNP ratios (below 200/50K), even with accuracies
as low as 0.2, pICA-R still benefits in sensitivities compared to blind ICA and pICA,
indicating a big tolerance of false inputs. Meanwhile, the reference-imposed FDR
remains below 0.05, and decreases to 0 with accuracies greater than 0.3. This effective
control on reference-imposed FDR is believed to result from a well maintained balance
between independence and closeness metric such that the latter never dominates to
excessively elevate the referential random loci. Based on the simulation results, a general
conclusion can be drawn that a relatively accurate reference is recommended for pICA-R.
Compared to a large number of reference loci with low confidence, a small set of reliable
reference loci would lead to a better performance. Retrospectively, through investigating
the sensitivity and reference-imposed FDR as functions of reference accuracy, we can
empirically infer the quality of a reference. The simulation shows that, if more than 10%
of the reference SNPs show up in the most significant (i.e., top component weights)
findings, the reference accuracy is most likely higher than 0.2 and, the reference benefits
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the performance. In contrast, a low ratio of reference loci in the most significant findings
usually indicates the distance metric being de-emphasized due to low reference accuracy.
In pICA-R, reference SNPs are predicted to contribute simultaneously to only a single
component. Therefore, it may be inappropriate to directly combine multiple presumed
susceptibility loci identified in univariate analyses, which may then result in a reference
containing true SNP hits from multiple components. In this case, the reference is
essentially of low accuracy as pICA-R is currently designed to optimize the distance
between the reference and one constrained component and the true hits from other
components cannot be recognized. Given a low-accuracy reference, minimizing distance
will contradict with maximizing independence, which can be captured by the online
monitoring of the overall independence. pICA-R will then adaptively adjust the constraint
weight to de-emphasize the distance metric to assure the integrity of independent
components (as reflected in simulations, Figure 4.4). When the distance metric is
significantly de-emphasized, pICA-R effectively converges with results from blind pICA.
While it is true that reference accuracy plays an important role in pICA-R
performance, this should not compromise the applicability of the model. First, we
implement a binary reference, thus users only need to determine whether the loci are
relevant or not to the trait of interest instead of specifying the accurate effect sizes.
Second, the model is highly robust to inaccurate reference SNPs. As demonstrated in
simulations, pICA-R outperforms blind methods with the accuracy as low as 0.2 when
the sample-to-SNP ratio is lower than 4.00×10-3 (Figure 4.3 and Figure 4.4). Last but not
least, while the choice of reference SNPs is informed by evidence, this is not necessarily
limited to association studies. Independent molecular, cellular or system biological
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knowledge can also guide the selection. Even when informed by association studies, an
enormous sample is not a necessity. Replication across studies can help increase
confidence in the selection. For example, an association is more likely to be true and
poses a good candidate for the reference if consistently observed in several independent
studies of small sample sizes. Overall, we believe that the large amount of available data
and information learned from previous studies are sufficient to generate testable
references for a particular research interest, which can be leveraged by our pICA-R
method to increase, broaden or deepen our knowledge at large.
A primary strategy to generate a testable reference is through dissecting the natural
LD blocks for individual genes. This is because genome-wide association study (GWAS)
is based on the premise that a causal variant is located on a haplotype, and thus a marker
allele in LD with the causal variant should show (by proxy) an association with the trait
of interest (Stranger et al., 2011). Therefore, SNPs in one LD cluster are more likely to
contribute simultaneously to one single component and serve as good candidates for
reference. Given the current formulization that one single component is constrained in
pICA-R, this primary strategy for reference generation can only test one LD referential
set at a time. To improve the robustness, we will extend pICA-R to accommodate
multiple referential sets where the interrelationships are unknown. The related contents
are presented in the next chapter.
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CHAPTER 5

PARALLEL

INDEPENDENT

COMPONENT

ANALYSIS WITH MULTIPLE REFERENCES

5. 1

Introduction

A key factor that affects the performance of pICA-R is the reference accuracy. As
shown in the previous chapter, degradation is expected in component, loading and
linkage accuracies when the reference accuracy is below 0.2. This raises an issue on how
an applicable reference can be effectively derived in real applications where the reference
accuracy cannot be reliably estimated. One primary strategy is to derive a referential SNP
set based on the natural LD clusters of individual genes. A marker allele in LD with the
causal variant should show (by proxy) an association with the trait of interest (Stranger et
al., 2011). Compared to random loci, LD loci are more likely to covary with a same
underlying pattern (e.g. the trait of interest) and be captured in one component in pICA-R
which inherits the linearly additive model from ICA. Based on this assumption, a
referential SNP set derived from LD clusters is considered more homogeneous and
exhibiting relatively high reference accuracy, which facilitates the pICA-R analysis.
While a single accurate referential SNP set is shown to greatly improve the
performance compared to blind approaches, a capability to accommodate multiple
referential SNP sets is desired in light of the real applications of pICA-R. For instance,
one challenging issue in imaging genetics studies is that, a complex genetic structure is
envisaged for plenty of neurological disorders which are polygenic and heterogeneous.
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Polygenicity means that a number of genetic variants with possibly small individual
effect sizes are involved in the etiology of a disease. Heterogeneity is often reflected in
phenotypic or endophenotypic complexity which might indicate contributions from
distinct pathological mechanisms. Therefore, computationally assessing multiple
referential SNP sets for potential convergence of functional influences on neurobiological
traits should help better delineate the genetic architecture underlying the complex
disorders.

5. 2

Method

Given the formularization of pICA-R, it is inappropriate to directly combine multiple
referential SNP sets, as this imposes an assumption that all the referential SNPs are
expected to contribute to the same component, which is not necessarily the case. Instead,
the extended approach, parallel ICA with multiple references, is designed to investigate
how each of the referential sets is represented in the observed data such that those
potentially related will be naturally grasped when they guide the algorithm to constrain
the same component.
Recall that in pICA-R, the reference is designed as a binary vector where candidate
causal loci are set to “1” and others set to “0”. When multiple referential sets are
involved, the reference vector is expanded into a reference matrix. Each row represents a
referential set which comprises a group of loci likely related. The interrelationship among
different reference vectors is to be investigated. Figure 5.1 and Equations (5.1)-(5.3)
illustrate the extended model, where the notations are consistent with those used for
pICA-R in the previous chapter. The observed dataset X (sample × feature) is
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decomposed into a linear combination of the underlying independent components, or
sources. S, A and W denote the component, mixing and unmixing matrices, respectively.
The subscript d runs from 1 to 2, denoting the data modality. The unmixing matrices W1
and W2 are iteratively updated to maximize the objective functions F1, F2 and F3. Similar
to single-reference pICA-R, F1 represents the objective function of the regular infomax
(Bell and Sejnowski, 1995b) for modality 1, and the inter-modality association function
F3 is designed to maximize the correlations computed over the columns of the loading
matrices A1 and A2. In contrast, F2, the objective function for modality 2, is modified so
that multiple components might be constrained to closely resemble the reference matrix
r. Specifically, when each row of r represents a referential set, the algorithm sequentially
works with each reference vector ri to determine the closest component and then apply
the constraint, as shown in (5.2). The subscript i denotes the row index in matrix r and I
denotes the total number of rows. Figure 5.1illustrates the measurement of closeness. For
a particular reference vector

, the referential loci are represented by ̃ , a subvector of

. The algorithm calculates the Euclidean distance between each of the components and
the reference for the referential loci ( ‖| ̃

|

̃ ‖ ), based on which the closest

component is selected to be constrained, such that the distance is further minimized.
̃

represents a subvector of the constrained component

(i.e. the kith row of S2);

denotes the kith row of W2 and ̃ denotes a submatrix of X2; ||·||2 represents the
L2-norm Euclidian distance, and λ is the weighting parameter.
(5.1)
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Figure 5.1: Parallel ICA with multiple reference sets. Each row (e.g.,
and
,)
represents a set of referential loci residing in one single LD cluster. In this demonstration,
and
constrain the same component (
) represented by
.
Again, the three objective functions (F1, F2 and F3) are optimized using gradient
maximization. For F1 and F3, the updating rules are same as those for single-reference
pICA-R, and we refer readers to Equations (4.4) and (4.6). For F2, two situations will be
discussed. (a) When reference vectors
components
and

and

and

select out different constrained

, the corresponding rows of the unmixing matrix

will be updated separately, as shown in (5.4). (b) When the two reference
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vectors select out the same constrained component
unmixing matrix

will be updated sequentially for

and Figure 5.1, this is essentially equivalent to
vector

, the corresponding row of the

harboring both

and

and

. As shown in (5.5)

being updated for a single-reference

and is expected to yield comparable performances

with single-reference pICA-R. Such, pICA-R is extended to accommodate multiple
referential sets without making any assumption on whether or not the loci highlighted in
different referential sets are independent from each other, and the constraint of each
referential set is applied based on how it is represented in the data.
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Simulation

Similar to single-reference pICA-R, the extended multi-reference approach was firstly
evaluated with simulated fMRI and SNP data for its effectiveness. As we already
compared pICA-R with other competing approaches (see chapter 4), the key point for the
extended approach then lied in whether it is able to correctly capture referential sets
contributing to the same component. Therefore, the simulation was focused on
investigating the true and false positive rates with respect to this issue. Again the
tolerance of reference accuracy was comprehensively assessed. For proof-of-concept, we
conducted the simulations with two referential sets imposed. However, the algorithm is
able to deal with more.
The simulated data consisted of 200 samples (i.e., subjects). Eight independent
vectors were randomly generated from normal distributions to form a mixing matrix for
the fMRI data. Subsequently, eight case-control patterns were correspondingly generated
through linear transformations of the fMRI mixing vectors with random Gaussian noises
superimposed, such that associations were built between fMRI and diagnosis. The
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case-control patterns would then be used in PLink (Purcell et al., 2007b) for simulating
SNP data.
The simulated fMRI data had a feature dimension of 40K voxels. Eight
non-overlapping brain networks were simulated using the SimTB toolbox ((Erhardt et al.,
2011), http://mialab.mrn.org/software) to serve as the fMRI components. The fMRI
observation matrix was then obtained as the product of the mixing and component
matrices with random Gaussian noises superimposed onto each sample. Similar to
single-reference simulations, the SNP data were simulated via PLink. The performances
of the approach was investigated with components accounting for different amounts of
variance in the data, which was achieved through adjusting the SNP dimensionality and
causal loci effect size. Eight non-overlapping SNP components were simulated using
PLink (Purcell et al., 2007a), each involving 150 causal loci. The SNP dimensionality
ranged from 50K to 500K, resulting in the sample-to-SNP ratio from 0.004 (200/50K) to
0.0004 (200/500K), and the causal loci ratio from 0.003 (150/50K) to 0.0003 (150/500K).
These eight SNP components consisted of 4 pairs, where each pair comprised two
components whose causal loci were linked to the same case-control pattern. Note that
PLink does not generate SNPs in LD. Thus through linking two components to the same
case-control pattern, we obtained two groups of SNPs associated with the same diagnosis
and fMRI loadings. A two-sample t-test showed that the correlations among SNPs linked
to the same diagnosis were not significantly different from the correlations among
randomly generated SNPs (p = 0.35). Evaluated with explained variances, the effect sizes
of individual causal loci ranged from 0.0037 to 0.1926.
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To evaluate the performance of the extended approach, we first investigated out of
100 runs, what would be the ratio for the algorithm to accurately detect the referential
sets contributing to the same SNP component and neurobiological trait, denoted as linked
reference matching ratio in the following text. Specifically, a reference matrix was
generated, with each vector harboring a referential set derived from one of the two groups
of causal loci that were linked to the same case-control pattern and fMRI loading. The
evaluation started with two accurate referential sets, each spanning 20 true causal loci.
Then referential sets spanning 40 loci of accuracies ranging from 0 to 0.5 were tested to
investigate the performance boundary. Equivalently, we also evaluated the ratio for the
algorithm to falsely constrain the same SNP component for two isolated referential sets,
denoted as isolated reference mismatching ratio. For this purpose, the reference matrix
was generated to harbor two referential sets derived from two groups of causal loci that
were linked to distinct case-control patterns. Again, the same range of reference
accuracies was evaluated, as for the linked reference matching ratio.
The model requires selection of the component number. In the simulations, the fMRI
component number was set to 8, the true component number for the simulated data, for
all tests. For the SNP modality, the number of components was in general selected to be
50 given our observation that the semi-blind pICA-R model tends to be robust to
over-estimation. However, when isolated reference mismatching ratio was evaluated with
two isolated referential sets, the SNP component number was set to 100. The reason is
the following. When ICA was applied to the genotype data, referenced PCA was
commonly employed for data reduction instead of regular PCA, where a case-control
pattern was employed such that top phenotype-related PCs, instead of those explaining
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the largest amounts of variance, were selected. Obviously, referenced PCA is not robust
to multiple phenotypic references, for which the top related PCs might be different. To
address this issue, in our simulation we ranked together the projected eigenvalues when
multiple phenotypic references were used and then selected out top related PCs. This
strategy favors an objective selection based on how phenotypes are represented in the
data. It should be noted that this is majorly for simulations to test the isolated reference
mismatching ratio and is not expected to be a common practice in real applications,
where isolated referential sets potentially contributing to different phenotypes should be
tested in two runs.
Besides the linked reference matching ratio and isolated reference mismatching ratio,
accuracies of genetic components, loadings, and inter-modality connections, as well as
the reference-imposed FDR were also evaluated for the extended approach. The SNP
component accuracy was assessed with the ratio of correctly identified causal loci to the
built-in true causal loci. The genetic loading accuracy was reported as the absolute value
of the correlation between the simulated case-control pattern and the extracted loadings.
The correlation between loadings of the two components (SNP and fMRI) most
resembling the ground truth of the two modalities, respectively, was calculated and
compared with the built-in correlation to reflect the linkage accuracy. In addition, when
two isolated referential sets were tested, the performance of a combined run was
compared with that of two separated runs. The former conducted the analysis with the
extended approach where two isolated referential sets were assessed simultaneously, and
the latter conducted two separate analyses with single-reference pICA-R. Due to the
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computation burden, we did this combined versus separate comparison only for one
dataset with a SNP dimensionality of 50K and median effect size of 0.059.

5. 4

Results

Overall, the extended approach successfully captured the reference structure when
two referential sets were assessed simultaneously.

Figure 5.2: Performance of parallel ICA with multiple references: (a) on simulated
datasets with different effect sizes when the sample-to-SNP ratio was controlled at 0.004
and causal loci ratio at 0.003; (b) on simulated datasets with SNP dimensionality ranging
from 50K to 500K, resulting in sample-to-SNP ratios from 0.004 to 0.0004 and causal
loci ratios from 0.003 to 0.0003, the median effect sizes were 0.059, 0.057 and 0.060,
respectively. Results were obtained with 20-loci references of accuracy 1. The error bars
reflect mean ± SD based on 100 runs.
Given referential sets of 20 true causal loci (accuracy = 1), the linked reference
matching ratio was 1 based on 100 runs, regardless of the causal loci effect size or SNP
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dimensionality. As demonstrated in (5.5), this is equivalent to one component being
constrained by a single reference vector harboring both referential sets. Figure 5.2 shows
the corresponding performances of component, loading and link accuracies, measured
with sensitivity and correlations, respectively. In agreement with single-reference
pICA-R, the extended approach showed robust performances under different scenarios.
Given a sample-to-SNP ratio of 0.004 (200/50K), the component accuracy remained
close to 0.5 when the median causal loci effect size was decreased to 0.03. Meanwhile,
consistent performances were observed when the sample-to-SNP ratio decreased from
0.004 to 0.0004 (200/500K).

Figure 5.3: Performance comparisons with 40-loci references of different accuracies: (a)
on simulated datasets with different effect sizes when the sample-to-SNP ratio was
controlled at 0.004 and causal loci ratio at 0.003; (b) on simulated datasets with SNP
dimensionality ranging from 50K to 500K, resulting in sample-to-SNP ratios ranging
from 0.004 to 0.0004 and causal loci ratios from 0.003 to 0.0003, the median effect sizes
were 0.059, 0.057, and 0.060, respectively. The error bars reflect mean ± SD based on
100 runs.
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As expected, linked reference matching ratio was significantly affected by reference
accuracies. Given 40-loci referential sets, a reference accuracy above 0.2 was required for
the algorithm to effectively capture the reference structure, as shown in Figure 5.3. When
the reference accuracy was below 0.2, the linked reference matching ratio was lower than
0.2, indicating that for more than 80 out of 100 runs, the algorithm did not constrain the
same SNP component for the two referential sets. Meanwhile, a dramatic improvement
was in general observed at the reference accuracy of 0.3 for the linked reference
matching ratio, which reached 0.9. When the reference accuracy was further increased to
0.5, a linked reference matching ratio of 1 was obtained regardless of the causal loci
effect size or SNP dimensionality, consistent with the previous observation for referential
sets spanning 20 true causal loci. With respect to component accuracies, the
performances of the extend approach were comparable to those of single-reference
pICA-R when the reference structure was correctly identified given relatively higher
accuracies (> 0.3). On the other hand, larger performance deviations were observed for
lower reference accuracies, which was possibly due to component splitting when the
algorithm could not identify the reference structure such that two distinct SNP
components were constrained for the two referential sets. Again the reference-imposed
component FDR was not affected by the reference accuracy, remaining below 0.05 for all
the tested scenarios.
When two isolated referential sets were assessed simultaneously, the isolated
reference mismatching ratio was below 0.05 for all the tested reference accuracies, as
shown in Figure 5.4. This suggests that there is a low chance for the algorithm to
mistakenly constrain the same component when the two referential sets are essentially not
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related. It was also noted that, when two isolated referential sets were assessed
simultaneously, it yielded (a) comparable component accuracies (Figure 5.4) to those
obtained from the single-reference analysis for referential set A; (b) degraded accuracies
for referential set B. Meanwhile, no significant difference in reference-imposed
component FDR was observed between combined and separate runs.

Figure 5.4: Performance comparisons with 40-loci references of different accuracies
when two isolated reference sets were assessed in a combined run (parallel ICA with
multiple references) or two separate runs (single-reference pICA-R), respectively. The
tested dataset has a sample-to-SNP ratio of 0.004 and a median effect size of 0.059. The
error bars reflect mean ± SD based on 100 runs. The isolated reference mismatching ratio
was reported for the combined runs.

5. 5

Discussion

The simulation results demonstrate that the extended approach helps capture the
embedded reference structure in a nonparametric manner. As illustrated in Figure 5.2,
when provided with accurate referential sets associated with the same trait of interest, the
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algorithm correctly recognizes that they contribute to the same component and applies the
constraints. The resulting component, loading and link accuracies are comparable to
those previously observed in single-reference analyses. In particular, reliable detection of
underlying reference structure is observed for a low sample-to-SNP ratio (200/500K)
given a median effect size around 0.06, confirming the feasibility of applying the
extended approach to real imaging genomics studies to analyze a million or so loci
provided that hundreds of subjects are available.
Meanwhile, it is noticed that reference accuracy plays an important role in the
performance of linked reference matching ratio for parallel ICA with multiple references.
As shown in Figure 5.3, for reference accuracies below 0.2, the linked reference
matching ratio is lower than 0.2. This is not surprising, as for the proposed data-driven
approach, when random loci are incorrectly selected to be referential, the distance
between the reference vector and the component is smeared and no longer distinguishes
itself from those randomly observed. On the other hand, it’s encouraging to observe a
dramatic improvement of linked reference matching ratio to around 0.9 at the reference
accuracy of 0.3, which is likely to achieve when using the strategy of deriving a single
referential set based on LD loci.
Besides reference accuracy, the performance of linked reference matching ratio is
also affected by causal loci effect size. Obviously, degradation is observed for data with
lower causal loci effect sizes (0.029), for which the linked reference matching ratio only
reaches 0.5 at a reference accuracy of 0.3, as shown in Figure 5.3. Interestingly, the
performance is less vulnerable to the increase of SNP dimensionality. This might be
attributable to the design of the model. Recall that the Euclidean distance is calculated
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between the component and the reference vector specifically for those referential loci.
Thus, an increased SNP dimensionality simply results in an increased number of
to-be-investigated loci, which might not significantly affect the estimated distance metric.
Instead, decrease in effect sizes is expected to increase the distance between the reference
vector and the true component, such that other components might by chance be closer to
the reference vector and selected for constraint, resulting in in a low linked reference
matching ratio.
While linked reference matching ratio is more sensitive to reference accuracy and
data properties, isolated reference mismatching ratio is less affected and reliably below
0.05 when two isolated referential sets are assessed simultaneously, as shown in Figure
5.4. Note that when the reference accuracy is 0, the two isolated referential sets
essentially consist of random loci, which is equivalent to the situation when linked
reference matching ratio is evaluated for two referential sets of accuracy 0. In both cases,
the chance is below 5% for the algorithm to constrain the same component for the two
tested referential sets, as consistently observed in Figure 5.3 and 5.4. This also applies to
the situations when the reference accuracy is increased for the two isolated referential
sets, as the added true causal loci of one set are essentially recognized as random loci by
the other set when they are indeed not related. Therefore, the linked reference matching
ratio is expected to remain below 0.05, regardless of reference accuracy.
When two referential sets associated with different phenotypes are assessed in one
run, the resulting performances might be affected by the data reduction if referenced PCA
is employed. In our simulation, we adopted an objective selection such that more related
information would be included for the phenotype better represented in the observed data.
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As shown in Figure 5.4, for referential set A, comparable component accuracies are
observed between combined and separate runs, while degradation is observed for
referential set B. It’s noted that the median causal loci effect sizes for these two
components are 0.059 and 0.057, respectively. Thus, more information related to
component A is included through referenced PCA, which results in higher sensitivity in
the combined runs.
Overall, parallel ICA with multiple references is able to assess multiple referential
sets simultaneously while the interrelationships are not known. Compared to
single-reference pICA-R, the extended approach is more flexible in dynamically
identifying the constrained component for individual referential set and allows some
extent of heterogeneity in the reference. Simulation results demonstrate high linked
reference matching ratio and low isolated reference mismatching ratio, confirming the
validity of Euclidean distance as a metric for the assessment of reference structure.
Meanwhile, some cautions need to be exercised when conducting an analysis. First, an
accurate reference is favored. Compared to single-reference pICA-R, the extended
approach is slightly more sensitive to reference accuracy. This is because when two
referential sets of low accuracies (e.g. accuracy <= 0.2) are employed, component
splitting is likely to happen if they fail to constrain the same component while some of
the referential loci are indeed related. A practical strategy is to derive individual
referential sets based on LD blocks of genes. In general SNPs in LD are more likely
associated with the same trait of interest, and hence contribute to the same component.
Second, when referenced PCA is employed for data reduction, it is not recommended to
test a variety of hypotheses in one single run. As different behavioral manifestations may
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involve different biological mechanisms, when one of the phenotypes is selected as a
PCA reference, the reduced data better represents mechanisms underlying this specific
phenotype than those underlying other phenotypes. Consequently, there is little chance to
identify components accurately representing those unattended mechanisms even if the
references are accurate. Instead, the extended approach is more suitable for assessing the
architecture of genes which, although previously implicated in the same biological
mechanism, still await investigations on their homogeneous or heterogeneous functional
influences on neurobiological conditions.
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CHAPTER 6

EXPLORATION OF SCANNING EFFECTS IN

MULTI-SITE STRUCTURAL MRI STUDIES

6. 1

Introduction

Structural magnetic resonance imaging (sMRI) is increasingly used to study
morphology of living brain given its non-invasive nature. Based on high resolution
T1-weighted images, measures can be derived to quantify brain structure for further
analysis such as assessment of neurological diseases (Fornito et al., 2009; Glahn et al.,
2008). A variety of computational methods have been developed to deal with the
anatomical complexity, one of those commonly used is voxel-based morphometry
(VBM) (Ashburner and Friston, 2000, 2005). VBM involves tissue segmentation, spatial
normalization and smoothing procedures, followed by voxelwise univariate statistical
tests on feature changes across subjects. This method has been successfully applied to
characterize structural abnormalities in a variety of diseases such as schizophrenia (SZ)
and Alzheimer’s disease (Ferreira et al., 2011; Giuliani et al., 2005; Honea et al., 2005) as
well as track the structural changes as a response of environmental factors (Maguire et
al., 2000).
Most sMRI studies are performed at a single site; however pooling of multi-site data
is becoming more common, especially imaging genetics studies. This is due to a desire
for a large sample size to provide sufficient statistical power for the investigation of
subgroups, or a rare condition, or a factor of relatively small effect size. In contrast to the
desire for data pooling, collaborative sMRI studies face some big challenges, one of
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which is that inconsistent collection platforms can introduce systematic differences to
distort the image information and confound the true effect of interest. In addition, even in
single-site studies a scanner will likely undergo hardware exchanges or software
upgrades over time, making it difficult to keep the status consistent over the period of a
longer study. Previous work has revealed scanning effects resulting from a number of
factors, including static magnetic field inhomogeneity, imaging gradient nonlinearity and
difference in subject positioning (Focke et al., 2011; Jovicich et al., 2006; Littmann et al.,
2006; Vovk et al., 2007). On the other hand, it is also noted that these scanning effects
may be orthogonal to and not necessarily interfere with the true effects of interest (Segall
et al., 2009; Stonnington et al., 2008), or that a specific statistical modeling will
ameliorate the scanning effects (Fennema-Notestine et al., 2007), which encourages more
efforts towards collaborative studies.
In the present study, we aim to explore how various scanning parameters influence
the sMRI image pattern and whether a correction is applicable. Through studying gray
matter concentration (GMC) images collected from a large cohort of 1,460 healthy
subjects, we expect to locate pivotal scanning parameters, which may be calibrated to
avoid significant systematic differences, or be selectively included as covariates in
post-hoc analyses. Specifically, ICA (Amari, 1998; Bell and Sejnowski, 1995a) is applied
to decompose the data into a linear combination of underlying sources, which are then
investigated for associations with various scanning parameters to assess the influence
(also called source-based morphometry (SBM) (Xu et al., 2009)). A correction procedure
has also been designed and tested in a second study (110 SZ patients versus 124 healthy
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controls), which allows evaluating the effectiveness in reducing scanning effects and in
particular, refining true effects of interest.

6. 2

Materials and Methods

BIG Data
Subjects: The exploratory study included 1,460 subjects from the ongoing Brain
Imaging Genetics (BIG) study, being conducted at the Radboud University Nijmegen
(Nijmegen, the Netherlands). The regional medical ethics committee approved the study
and all subjects provided written informed consents. The cohort included in this study
consisted of 617 males (age: 23.35±4.22) and 843 females (age: 22.69±3.66) whose MRI
scans were pooled from various studies conducted since 2003. All subjects are healthy,
highly educated adults of Caucasian origin, and free of neurological or psychiatric history
according to self-reports.
Neuroimaging: Structural images were acquired at the Donders Centre for Cognitive
Neuroimaging (Nijmegen, the Netherlands). Table 6.1 provides a summary of the
scanning settings. Subjects were scanned using different scanners, i.e. 1.5T Siemens
Avanto and Sonata, as well as 3.0T Siemens Trio and TIM Trio. Transmitting and
receiving coils also differed across subjects. A standard coronal T1-weighted
three-dimensional magnetization prepared rapid gradient echo (MP-RAGE) sequence was
employed, while some variations were observed in repetition, inversion and echo time, as
well as pixel bandwidth and flip angle. The use of parallel imaging (GRAPPA) with an
acceleration factor of 2 was also included.
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Table 6.1: Summary of BIG scanning parameters.
Scanning parameter

Variations across subjects

StationName

avanto (572), sonata (175), trio (56), triotim (657)

SequenceName

*tfl3d1 (16), *tfl3d1_ns (1101), spc3d1rr282ns (6), tfl3d1 (2), tfl3d1_ns (335)

SliceThickness

0.8 (2), 0.84 (2), 0.87 (1), 0.91 (1), 1 (1453), 1.1 (1)

RepetitionTime

1660 (3), 1960 (16), 2250 (645), 2300 (690), 2730 (100), 3200 (6)

EchoTime
InversionTime

2.02 (3), 2.86 (1), 2.92 (28), 2.94 (1), 2.95 (572), 2.96 (193), 2.99 (15), 3.03 (403),
3.04 (1), 3.08 (1), 3.11 (1), 3.13 (1), 3.55 (2), 3.68 (162), 3.93 (54), 4.01 (6), 4.43 (9), 4.58 (4), 5.59 (3)
1000 (100), 1100 (704), 750 (3), 850 (645), 900 (2), null (6)

NumberOfAverages

1 (1457), 2 (3)

MagneticFieldStrength

1.494 (112), 1.5 (635), 2.89362 (56), 3 (657)

NumberOfPhaseEncodin 176 (3), 196 (6), 253 (5), 255 (658), 256 (786), 320 (2)
gSteps
PercentPhaseFieldOfVie 100 (1441), 68.75 (3), 81.25 (16)
w
PixelBandwidth
130 (714), 140 (735), 240 (2), 260 (3), 751 (6)
TransmittingCoil

body (1259), cp_head (53), txrx_head (148)

AcquisitionMatrix

[0 256 176 0] (3),[ 0 256 208 0] (16), [0 256 256 0] (1433), [0 256 258 0] (6), [0 320 320 0] (2)

FlipAngle

120 (6), 15 (645), 7 (100), 8 (707), 9 (2)

PixelSpacing

[0.5 0.5] (17), [0.8 0.8] (2), [1.0 1.0] (1440), [1.1 1.1] (1)

LAccelFactPE

1 (787), 2 (662), 3 (3), 4 (5), null (3)

tcoilID/ReceivingCoil

32ch_head (281), 8ch_head (667), body (1), cp_head (430), headmatrix (78), null (3)

Note: Each scanning setting is followed by the number of subjects that have been scanned using this setting. Scanning
parameters with small variances across the subjects (displayed in gray) are excluded from the subsequent analysis.

MCIC Data
Subjects: The second dataset included 234 subjects from the Mind Clinical Imaging
Consortium (MCIC) study (Gollub et al., in press), a collaborative effort of four research
teams from University of New Mexico-Mind Research Network, Massachusetts General
Hospital, University of Minnesota and University of Iowa. The institutional review board
at each site approved the study and all subjects provided written informed consents. The
cohort consisted of 110 SZ patients and 124 healthy controls. All healthy subjects were
screened to ensure that they were free of any medical, neurological or psychiatric
illnesses, including any history of substance abuse. The inclusion criteria for patients
were based on a diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
confirmed by the Structured Clinical Interview for DSM-IV-TR disorders (SCID, (First et
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al., 1997)) or the Comprehensive Assessment of Symptoms and History (CASH,
(Andreasen et al., 1992)). Table 6.2 provides the demographic information.
Neuroimaging: The brain images were coronal T1-weighted MRIs collected at
multiple sites. Subjects were scanned using different scanners, i.e. 1.5T Siemens Sonata
and GE Signa, as well as 3.0T Siemens Trio. Closely matched acquisition sequences were
used. Compared to the BIG data, the MCIC data have relatively limited scanning
information, as summarized in Table 6.3 (Segall et al., 2009). Slight collinearity was
observed between SZ diagnosis and scanner (r2 = 0.043), as well as slice thickness (r2 =
0.039).
Table 6.2: Demographic information of MCIC subjects.
Demographics
Sex
Age
Race/Ethnicity

Collection site

SZ (110)

HC (124)

Male

82

75

Female

28

49

Mean ± SD

35 ± 11

32 ± 11

Range

18 - 60

18 - 58

Caucasian

83

110

African American

17

4

Asian

5

5

American Indian

1

1

Unreported

4

4

Harvard

28

23

Iowa

32

60

Minnesota

29

18

New Mexico

21

23

Table 6.3: Summary of MCIC scanning parameters.
Site

Scanner

Field
strength (T)

TR/TE
(ms)

Slice
thickness (mm)

Bandwidth

Voxel
dimensions (mm)

Sequence

M021 (51)

Siemens Sonata

1.5

12/4.76

1.5

110

0.625 × 0.625 × 1.5

Gradient Echo

M522 (92)

GE Signa

1.5

20/6

1.6

122

0.6641 × 0.6641 × 1.6

Gradient Echo

M554 (47)

Siemens Trio

3

2530/3.81

1.5

110

0.625 × 0.625 × 1.5

MP-RAGE

M871 (44)

Siemens Sonata

1.5

12/4.76

1.5

110

0.625 × 0.625 × 1.5

Gradient Echo

Note: Each site is followed by the number of subjects that have been scanned at that station.
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Preprocessing
The T1-weighted sMRI data were preprocessed in Statistical Parametric Mapping 5
(SPM5, http://www.fil.ion.ucl.ac.uk/spm) using unified segmentation (Ashburner and
Friston, 2005), in which image registration, bias correction and tissue classification are
performed using a single integrated algorithm. Brains were segmented into gray matter,
white matter and cerebrospinal fluid and non-linearly transformed into the ICBM152
standard space (without Jacobian modulation). The resulting GMC images were re-sliced
to 2 × 2 × 2 mm, with a field-of-view of 91 × 109 × 91 voxels. In the subsequent quality
check, we excluded 4 subjects from the BIG data whose GMC images were four standard
deviations away from the average GMC image across all subjects. No outliers were found
for the MCIC data. A mask was then generated (mean GMC > 0) to include only the
segmented gray matter voxels, resulting in a total of 298,707 voxels for the BIG data and
292,998 voxels for the MCIC data. Finally, a voxelwise linear regression analysis was
performed to remove the effects of age and sex.
Analysis
The unsmoothed GMC images corrected for age and sex were investigated for
associations with scanning parameters in SBM model, as illustrated in Figure 6.1. SBM
analysis consists of data decomposition using ICA (infomax) (Amari, 1998; Bell and
Sejnowski, 1995b) and association tests between loadings and scanning parameters. First,
spatial ICA is applied to decompose the group GMC images into a linear combination of
independent components (ICs), or sources, as illustrated in Figure 6.1.1 and (6.1). X, A
and S denote the observed data, loading matrix and component matrix, respectively. Each
row of S represents an underlying component and each column of A represents the
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loadings associated with one single component. The subscripts m, n and l denote the
number of samples, voxels and components, respectively. After data decomposition, each
of the extracted loadings (i.e. each column of A) is then assessed for association with
each continuous or categorical scanning parameter using regression or ANOVA,
respectively. The pairwise association tests result in a series of p-values. Given the
dependence among scanning parameters, we choose to estimate the threshold for
significant associations (pth) based on the p-value distribution. Specifically, we plot the
p-values (-log10(p)) in a descending order and then perform linear fits to the two segments
of the curve, as shown in Figure 6.1.3. The intersection A of the fitted lines L1 and L2 is
then determined. Subsequently, we connect the origin and the intersection A to obtain the
line L3, which is extended to intersect the p-value curve at the point B. The p-value
corresponding to B is then selected as the threshold p-value. Compared with the
commonly used FDR control, our approach is conservative and yields a more stringent
threshold p-value.

[

]

[

]

[ ]
(6.1)

Based on the estimated threshold p-value (pth), the scanning parameters significantly
affecting (p <= pth) the image values and the IC loadings can be identified. To be more
cautious, the identified components are also examined for associations with traits of
interest. If a component is identified as scanning-related while not exhibiting any
significant effect of interest, a correction can then be performed to eliminate the
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scanning-related IC to improve data integrity. For instance, if the kth component is to be
corrected, we simply subtract the reconstructed Xk from the original dataset X to
eliminate the variance induced by that factor, as illustrated in (6.2). The corrected data
are denoted as Xc.
(∑

)

(

)

(6.2)

Figure 6.1: A flow chart of the SBM model.
The above procedure was applied to the BIG data to explore the pivotal parameters
significantly affecting the image pattern. We first excluded scanning parameters with few
variations across the subjects (displayed in gray in Table 6.1). Then we performed a
pruning process to further exclude highly collinear (r2 > 0.85) parameters, after which 8
parameters were retained. In particular, the inversion time (TI) was modeled as a function
of the field strength (i.e. inversion time per field strength), as the direct effect of TI
depends on the relaxation times which are different per field strength. In addition, for
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each subject, we calculated the signal-to-noise ratio (SNR) of the image, which is
proportional to the ratio of the average T1-contrast in the gray and white matter regions
over the standard deviation of the T1-contrast in air regions (Henkelman, 1985), as
described in (6.3). The gray and white matter regions are defined as voxels exhibiting
gray or white matter concentrations greater than 0.5, and the air regions are voxels with a
relatively low signal intensity, as shown in (6.3). The SNR parameter was also
investigated for its effect on the image pattern.
(

)
(

{

)
(

)}

(6.3)

Besides the exploration with the BIG data, we evaluated the detection and correction
procedure in a second dataset by examining GMC images of 234 subjects (110 SZ
patients and 124 healthy controls) from the MCIC study. First the data were corrected
using SBM and general linear model (GLM), respectively. The SBM correction used the
same procedure as described above, where components were extracted and subsequently
assessed for associations with three scanning parameters while controlling for SZ
diagnosis. The included parameters were scanner which was completely collinear with
TR/TE (as shown in Table 6.3), field strength which was collinear with sequence, as well
as slice thickness which was collinear with bandwidth and voxel dimensions. For GLM
correction, the same three scanning parameters and SZ diagnosis were included as
predictors. The estimated scanning effects were then regressed out at each voxel from the
original data. The uncorrected, SBM- and GLM-corrected data were subsequently
compared regarding the scanning and SZ effect sizes. Specifically, we investigated the
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scanning and disease effects using both component (ICA) and voxelwise (VBM)
approaches. For ICA, the scanning and SZ effects were assessed based on the
associations of extracted IC loadings with scanning parameters and SZ diagnosis. For
VBM, a univariate analysis was performed to examine the associations between GMC
and scanning parameters or SZ diagnosis at each voxel. Then voxels exhibiting
significant scanning or SZ effects were identified using a false discovery rate (FDR)
control for multiple comparisons.
Component Number Selection
PCA was applied before ICA for data whitening and reduction. It was noted that the
PC variance curve turned between component 50 and 100, and the top 100 components
explained a relatively larger amount of variance than the remainder. We thus performed
ICA with the component numbers from 50 to 100, and found that the most significant
scanning-related components (due to magnetic field strength and receiving coil) remained
stable within the tested range. Meanwhile, with the increase of component numbers, edge
effects appeared to be refined, manifested as increases in the level of significance. Given
these observations, we chose to perform the SBM analysis with a component number of
100.

6. 3

Results

BIG Data
We applied ICA to extract 100 components from the GMC images. The 100 resulting
ICs were then assessed for associations with 9 scanning parameters, as listed in Table 6.4.
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Based on the resulting p-values, the threshold of significance (pth) was estimated to be
1.40×10-23, as shown in Figure 6.1.3. Nine ICs were significantly associated (p <= pth,
highlighted in bold in Table 6.4) with various parameters, including magnetic field
strength and receiving coil. Figure 6.2 shows the spatial maps of the scanning-related ICs,
thresholded at |Z| > 2.

Figure 6.2: Spatial maps of the scanning-related components identified in the BIG data.
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Table 6.4: Scanning effects in the BIG sMRI data.
Scanning/IC Index

1

3

5

7

9

StationName

1.65E-40

1.44E-52

1.30E-28

2.98E-63

SequenceName

6.64E-01

1.91E-01

9.45E-01

9.41E-21

TI-FieldStrength

2.08E-11

2.73E-63

2.93E-32

FieldStrength

2.40E-05

3.98E-47

PixelBandwidth

8.86E-10

TransmittingCoil

1.12E-16

laccelFactPE

20

30

74

97

1.48E-241 9.80E-38

1.63E-20

7.80E-98

1.24E-25

6.21E-17

6.01E-01

9.28E-01

3.10E-03

2.73E-03

3.64E-06

5.56E-239 6.10E-52

3.09E-29

1.32E-28

1.09E-18

2.11E-05

4.62E-07

4.44E-216 1.65E-28

3.50E-23

2.89E-23

1.45E-21

6.17E-52

2.25E-08

3.95E-11

2.63E-247 1.50E-27

1.13E-21

2.73E-23

7.89E-19

7.27E-08

8.09E-10

1.22E-47

2.73E-26

1.86E-03

5.91E-05

9.46E-14

1.26E-07

4.68E-13

2.77E-09

1.23E-12

7.78E-16

6.76E-15

1.74E-25

1.28E-04

3.91E-08

2.24E-03

tCoilID

3.83E-04

1.65E-15

1.06E-03

3.86E-115 1.50E-22

1.85E-10

2.11E-01

6.25E-11

3.07E-06

SNR

6.79E-01

8.34E-01

3.10E-06

1.40E-23

5.46E-05

1.75E-03

2.20E-01

5.02E-01

1.05E-06

Note: Significant scanning effects (p < pth) are highlighted in bold.

Table 6.5: Talairach regions of the scanning-related components (BIG data).
Component

Brain region

Brodmann area

L/R volume (cm3)

L/R random effects, max Z (x,y,z)

IC3 pos

Superior Frontal Gyrus

8, 6, 9, 10, 11

9.1/10.2

3.73(-6,45,46)/4.07(4,45,46)

Middle Frontal Gyrus

9, 6, 8, 10, 46

5.8/5.4

3.12(-30,46,35)/2.77(22,22,58)

Postcentral Gyrus

5, 7, 3, 40, 2, 1

3.4/3.5

2.62(-12,-43,70)/2.60(16,-45,69)

Inferior Parietal Lobule

40, 7, 39, 2

2.9/2.8

2.64(-50,-52,50)/2.88(48,-44,54)

Superior Parietal Lobule

7

2.3/2.6

2.73(-34,-49,61)/3.01(24,-57,62)

Precentral Gyrus

6, 4, 9, 44

2.1/2.4

2.55(-46,-1,53)/2.57(22,-20,67)

Precuneus

7, 19, 39, 31

1.3/1.7

2.03(-22,-71,51)/2.51(4,-49,63)

3.7/4.8

7.75(-30,-14,1)/8.53(28,-17,3)

IC3 neg

IC7 pos

IC9 pos
IC97 pos

Lentiform Nucleus
Middle Temporal Gyrus

21, 20, 39, 37, 22, 19, 38

1.7/1.4

7.29(-42,1,-29)/6.68(53,-37,-3)

Precuneus

7, 31, 19, 39

1.7/1.1

7.50(-22,-68,33)/5.72(16,-47,34)

Middle Frontal Gyrus

10, 46, 8, 6, 11, 9, 47

1.5/0.9

6.36(-32,38,17)/6.35(40,13,20)

Superior Temporal Gyrus

22, 13, 38, 39, 21, 41

1.4/0.8

6.18(-53,0,-3)/5.77(46,-42,24)

4.2/4.4

6.00(-10,-23,1)/6.07(8,-23,1)

Thalamus
Superior Temporal Gyrus

22, 41, 13, 39, 38, 21, 42

1.5/1.8

4.75(-50,-17,5)/6.79(44,-25,5)

Middle Temporal Gyrus

21, 37, 22, 19, 39, 20

1.9/1.0

3.74(-57,7,-19)/3.65(50,-26,-7)

Middle Frontal Gyrus

10, 6, 9, 11, 8, 46, 47

1.1/1.2

4.10(-26,64,6)/3.28(26,32,26)

2.2/2.7

5.48(-6,-29,-4)/5.54(6,-29,-5)

Thalamus
Rectal Gyrus

11

0.9/1.0

4.80(-10,16,-23)/7.18(4,14,-21)

Superior Temporal Gyrus

38, 22, 13, 41, 42, 21, 39

4.2/3.8

6.58(-42,11,-16)/7.18(40,11,-16)

Anterior Cingulate

25, 24, 33, 32

2.7/0.4

6.77(0,6,-5)/4.46(2,3,-10)

Insula

13, 22, 40, 41, 47

2.4/3.2

5.91(-44,-11,10)/6.40(44,-6,0)

Parahippocampal Gyrus

34, 28, 35, 27, 30, 19, 36

2.3/2.0

8.08(-10,-9,-16)/8.09(10,-7,-18)

Inferior Frontal Gyrus

47, 13, 46, 44, 9, 45, 11

1.7/1.8

6.23(-40,15,-16)/6.90(38,13,-17)

Medial Frontal Gyrus

25, 10, 9, 6, 11, 8, 32

1.7/0.8

4.66(0,20,-18)/4.72(10,7,-19)

1.6/0.8

8.26(0,-16,1)/7.77(6,-31,3)

1.4/0.1

4.80(0,15,27)/3.48(8,-31,35)

1.3/1.2

7.69(-6,10,3)/7.39(6,6,5)

Thalamus
Cingulate Gyrus

24, 32, 31, 23

Caudate
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Figure 6.3: Boxplots of two components exhibiting the most significant scanning effects
in the BIG data; (a) IC9 loadings versus magnetic field strength-inversion time-pixel
bandwidth; (b) IC7 loadings versus receiving coil.
IC1, 5, 20, 30 and 74 reflected likely scanning effects at brain edges, while IC97
reflected scanning effects in the ventricle region. IC9 was predominantly located in the
brainstem region and exhibited the most significant scanning effect, associated with
station, TI-field strength, magnetic field strength and pixel bandwidth, among which
slight collinearity (r2 > 0.088) was observed. Specifically, 634 out of 1,460 subjects were
scanned in 1.5T scanners with a 850ms inversion time and 140Hz pixel bandwidth. These
subjects exhibited higher regional GMC in IC9 compared to 704 subjects scanned in 3T
scanners with a 1,100ms inversion time and 130Hz pixel bandwidth, as shown in Figure
6.3a. Meanwhile, the type of receiving coil showed a unique effect on IC7. This
component was primarily localized to the thalamus region and reflected higher regional
GMC in subjects scanned with multichannel phased-array coils, as shown in Figure 6.3b.
Table 6.5 provides a summary of the Talairach atlas labels (Lancaster et al., 1997;
Lancaster et al., 2000) of for IC3, 7, 9 and 97 thresholded at |Z| > 2. It needs to be pointed
out that in this work the components were mapped to the nearest gray matter, therefore
brainstem areas were not included in the table.
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MCIC Data
We applied the same procedure to the MCIC GMC images. 100 ICs were extracted
and assessed for associations with scanner, field strength and slice thickness, while
controlling for SZ diagnosis. The threshold of significance (pth) was estimated to be
5.28×10-3, based on which 8 ICs were identified as scanning-related, as summarized in
Table 6.6. Figure 6.4 shows the spatial maps of these ICs, thresholded at |Z| > 2. It can be
seen that scanning effects were again observed at brain edges, as represented by IC9, 63
and 92, as well as in the ventricle region, as reflected by IC 98. For the remaining
scanning-related components, Table 6.7 provides a summary of the Talairach atlas labels
of mapped gray matter regions with components thresholded at |Z| > 2. The most
significant scanning effect was observed in IC 53 (inferior temporal region), associated
with scanner and field strength. Again moderate collinearity was observed between these
2 parameters (r2 > 0.64). Boxplots illustrated that scans acquired with lower field strength
and shorter TR exhibited higher regional GMC in IC53, as shown in Figure 6.5. Finally
the 8 scanning-related components were used for SBM-based data correction.

Table 6.6: Scanning effects in the MCIC sMRI data.
Scanning / IC Index

7

9

33

38

53

63

92

98

Scanner

2.06E-02

1.94E-05

5.51E-03

5.18E-03

8.62E-53

2.68E-20

2.71E-09

2.96E-04

FieldStrength

2.87E-01

3.33E-06

3.98E-01

8.17E-01

3.57E-49

1.54E-02

1.02E-01

1.54E-03

SliceThickness

5.28E-03

1.49E-01

1.37E-03

3.84E-03

5.88E-02

4.14E-21

4.47E-10

4.69E-04

Note: Significant scanning effects (p < pth) are highlighted in bold.
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Table 6.7: Talairach regions of the scanning-related components (MCIC data).
Component

Brain region

Brodmann area

L/R volume (cm3) L/R random effects, max Z (x,y,z)

IC7 pos

Middle Frontal Gyrus

11, 9, 8, 6, 46, 10, 47

2.7/2.1

4.76(-36,40,-10)/4.13(38,21,30)

Inferior Frontal Gyrus

47, 9, 44, 45, 13, 10, 46

1.6/1.2

3.83(-55,15,29)/3.91(32,13,-17)

Superior Frontal Gyrus

9, 6, 8, 10, 11

1.4/2.1

4.30(-16,58,28)/4.86(16,54,32)

Superior Temporal Gyrus

21, 22, 39, 42, 38, 41, 13

1.4/1.9

4.48(-59,-8,-1)/4.34(40,-55,27)

Middle Frontal Gyrus

6, 9, 11, 10, 8, 46, 47

2.6/2.4

4.32(-38,27,28)/4.79(28,8,44)

Middle Temporal Gyrus

20, 39, 21, 19, 22, 37, 38

2.1/2.2

5.20(-53,-43,-10)/4.97(42,-59,20)

Middle Frontal Gyrus

9, 6, 46, 10, 8, 11, 47

5.3/2.8

7.17(-36,13,31)/5.41(36,14,49)

Superior Temporal Gyrus

41, 39, 42, 22, 38, 13, 21

3.8/3.0

8.24(-46,-39,6)/5.15(30,8,-29)

Superior Frontal Gyrus

8, 6, 10, 11, 9

3.6/2.9

4.55(-12,30,48)/5.52(38,16,47)

Precuneus

39, 7, 31, 19

3.3/3.0

7.03(-34,-62,36)/4.16(20,-76,28)

Precentral Gyrus

9, 44, 6, 3, 43

3.2/1.6

7.65(-36,11,31)/7.28(48,12,10)

Middle Temporal Gyrus

22, 21, 39, 37, 20, 38, 19

3.0/2.5

7.20(-48,-39,6)/5.96(55,-26,-10)

Inferior Parietal Lobule

39, 40, 7, 2

2.6/1.6

7.48(-36,-62,38)/4.45(44,-48,45)

Inferior Frontal Gyrus

44, 9, 46, 45, 13, 47, 10, 11 2.2/2.5

6.17(-34,9,29)/7.59(48,12,12)

Middle Frontal Gyrus

6, 8, 10, 9, 46, 11, 47

3.3/2.3

5.10(-36,10,47)/4.57(38,14,53)

Superior Frontal Gyrus

6, 10, 8, 9, 11

2.8/2.5

4.99(-20,58,25)/5.34(12,22,58)

Middle Temporal Gyrus

39, 21, 20, 19, 37, 22, 38

2.2/1.9

5.40(-30,-61,31)/4.75(55,-9,-18)

Inferior Parietal Lobule

40, 7, 39

2.2/1.3

6.11(-38,-49,39)/4.23(65,-42,24)

Precuneus

7, 31, 19, 39

2.0/2.1

8.09(-24,-60,36)/4.63(14,-59,31)

Middle Frontal Gyrus

10, 8, 6, 9, 11, 46, 47

3.4/2.6

6.06(-36,39,13)/5.14(32,37,11)

Superior Frontal Gyrus

10, 6, 9, 8, 11

2.4/1.9

4.97(-24,44,18)/4.50(20,43,38)

Cuneus

18, 7, 19, 17, 30, 23

2.2/2.3

6.07(-20,-81,21)/5.55(16,-74,26)

2.1/1.0

5.52(-12,-41,6)/4.35(24,-32,-9)

IC7 neg
IC33 pos

IC33 neg

IC38 pos

Parahippocampal Gyrus

IC38 neg

IC53 pos

IC53 neg

30, 19, 37, 36, 27, 28, 35

Lingual Gyrus

19, 18:*, 17, 30

1.9/1.2

4.30(-20,-95,-2)/4.46(16,-47,-3)

Inferior Frontal Gyrus

9, 47, 45, 46, 13, 10, 44, 6

1.5/1.8

4.74(-36,9,25)/4.33(30,28,-13)

Middle Frontal Gyrus

46, 9, 10, 6, 8, 11, 47

2.9/1.9

4.65(-42,51,14)/3.83(32,23,38)

Superior Frontal Gyrus

10, 6, 9, 11, 8

2.1/1.4

5.40(-20,46,23)/4.02(12,56,30)

Middle Temporal Gyrus

22, 37, 39, 19, 21, 20, 38

1.8/1.9

4.80(-50,-41,4)/4.12(42,-55,-2)

Parahippocampal Gyrus

30, 35, 27, 36, 28, 34, 19

1.8/0.9

6.64(-8,-39,4)/4.03(10,-41,-1)

Superior Temporal Gyrus

38, 39, 21, 41, 22, 42, 13

1.6/1.5

3.56(-46,-39,6)/4.46(24,8,-26)

Inferior Frontal Gyrus

45, 44, 47, 10, 9, 11, 13, 46 1.5/1.5

5.66(-38,45,0)/4.65(34,32,-18)

Inferior Temporal Gyrus

20, 21, 37, 19

3.5/3.4

10.76(-46,-21,-28)/8.66(46,-21,-28)

Superior Frontal Gyrus

11, 6, 10, 8, 9

3.1/2.7

6.24(-8,57,-23)/5.41(10,53,-23)

Middle Frontal Gyrus

11, 9, 10, 8, 46, 6, 47

3.0/2.1

4.01(-32,39,11)/4.33(42,48,-14)

Middle Temporal Gyrus

38, 39, 22, 21, 20, 37, 19

2.5/2.1

4.46(-36,10,-37)/4.36(55,-47,2)

Fusiform Gyrus

20, 36, 18, 19, 37

2.3/2.6

8.67(-50,-23,-27)/9.08(50,-25,-26)

Inferior Frontal Gyrus

47, 9, 11, 45, 46, 13, 44, 10 1.9/1.6

3.72(-50,38,-14)/3.56(53,3,27)

Superior Temporal Gyrus

38, 22, 13, 39, 42, 41, 21

1.7/2.4

4.42(-22,10,-36)/5.44(30,4,-39)

Precentral Gyrus

6, 4, 44, 9, 13, 43, 3

3.8/4.2

4.56(-30,-7,52)/4.84(18,-18,65)

Superior Frontal Gyrus

6, 8, 11, 9, 10

3.4/2.5

4.64(-8,3,68)/5.54(14,-12,71)

Middle Frontal Gyrus

6, 11, 8, 46, 10, 9, 47

2.2/1.2

5.57(-20,-1,61)/4.80(18,-7,59)

Medial Frontal Gyrus

6, 9, 10, 8, 25, 32, 11

1.9/2.4

4.64(-6,-20,71)/5.01(6,-20,71)
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Figure 6.4: Spatial maps of the scanning-related components identified in the MCIC
data.
Table 6.8: Comparisons of the scanning and SZ effects in the uncorrected, SBMand GLM-corrected data evaluated with ICA and VBM (MCIC data).
a. ICA (p-value)

Uncorrected

SBM-corrected

GLM-corrected

Scanner
MagneticFieldStrength
SliceThickness
SZ

8.62E-53
3.57E-49
4.14E-21
5.50E-06 (IC94)
1.72E-05 (IC98)
3.00E-04 (IC53)
2.36E-03 (IC7)

0.01
0.05
0.01
5.55E-07 (IC81)

0.32
0.48
0.35
1.40E-06 (IC12)
1.72E-04 (IC15)
7.24E-04 (IC34)
7.80E-04 (IC91)

b. VBM (number of voxels passing FDR)

Uncorrected

SBM-corrected

GLM-corrected

Scanner
MagneticFieldStrength
SliceThickness
SZ

20265
22318
10623
421

0
0
0
14

0
0
0
228
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Figure 6.5: Boxplots of the component exhibiting the most significant scanning effect in
the MCIC data; (a) IC53 loadings versus magnetic field strength-Sequence; (b) IC53
loadings versus TR/TE.
Both SBM and GLM correction appeared to effectively eliminate the scanning effects
when evaluated with ICA, as summarized in Table 6.8a. Meanwhile, the SZ effect was
refined with increasing significance levels. Figure 6.6a shows the spatial maps of the
SZ-related components (thresholded at |Z| > 2) identified in the uncorrected, SBM- and
GLM-corrected data. It can be seen that the mapped brain regions were highly consistent,
highlighting a frontal-temporal network. IC94 identified in the uncorrected data exhibited
a SZ effect with a p-value of 5.50×10-6 while controlling for scanning parameters. IC12
identified in the GLM-corrected data exhibited a more significant effect with p-value
decreasing to 1.40×10-6. The most significant SZ effect was observed from IC81
identified in the SBM-corrected data, presenting a p-value of 5.55×10-7, as shown in
Table 6.8a. The uncorrected data also presented marginal SZ effects captured by IC7, 53
and 98, whose spatial maps have been illustrated in Figure 6.4. Marginal SZ effects were
also observed in the GLM-corrected data, as captured by IC15, 34 and 91, whose spatial
maps are illustrated in Figure 6.6b.
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Figure 6.6: Spatial maps of the SZ-related components identified with ICA (|Z| > 2): (a)
the frontal temporal network identified in the uncorrected (IC94), GLM-corrected (IC12)
and SBM-corrected (IC81) data, respectively; (b) components exhibiting marginal SZ
effects in the GLM-corrected data.
For VBM analyses, no voxels exhibited significant scanning effects passing FDR
control after either SBM or GLM correction while number of voxels exhibiting
significant SZ effect decreased after correction, as summarized in Table 6.8b. In the
uncorrected data, 421 voxels showed SZ effect with scanning parameters included as
covariates. In the SBM- and GLM-corrected data, 14 and 228 SZ-related voxels were
identified, respectively. When we used a liberal threshold of 0.05, 29,853 voxels showed
SZ effect in the uncorrected data, 23,836 voxels in the SBM-corrected data and 28,117
voxels in the GLM-corrected data. Figure 6.7 illustrates the spatial maps of the
highlighted voxels for the three cases, where the uncorrected and the GLM-corrected data
presented highly comparable maps, highlighting more voxels in the brainstem region
compared to the map presented by the SBM-corrected data.
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Figure 6.7: Spatial maps of the SZ-related voxels (p < 0.05) identified with VBM in the
uncorrected, SBM-corrected and GLM-corrected data, respectively.

6. 4

Discussion

Pooling of multi-site structural MRI scans is desired in large scale brain morphometry
analyses, which lead to increased statistical power and provide opportunities to identify
reliable biomarkers. However, the true effect of interest may be confounded by the
systematic differences introduced by inconsistent acquisition schemes and scanning
platforms. This issue is especially inevitable in longitudinal studies. Thus it becomes
important to investigate the image comparability when different scanning platforms are
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involved. In this study, we explore the effects of various scanning parameters and
determine if a data correction is applicable in the SBM framework. The exploration was
performed with GMC images collected from 1,460 healthy subjects. As expected, we
observed significant scanning effects in distributed brain regions. The most pronounced
effects were observed from magnetic field strength and receiving coil. In the second
study with the MCIC data of 110 SZ patients and 124 healthy controls, the results
confirmed significant scanning effects. In addition, it was also demonstrated that the
SBM approach effectively separated scanning effects from the SZ-related GMC changes,
thus enabling a correction which helped refine the true effect of interest.
BIG Data
In the exploration with the BIG data, the most significant scanning effect is observed
in IC9. This component highlights the brainstem region, where the GMC exhibits
differences among subjects scanned at various stations, which primarily involve
differences in magnetic field strength, inversion time and pixel bandwidth. Magnetic field
strength affects the T1-relaxation and, hence, the imaging contrast between gray and
white matter (Duewell et al., 1996), which is consistent with our observation. Higher
field strength also results in increased magnetic susceptibility artifacts (Bernstein et al.,
2006). The brainstem is particularly prone to these artifacts (Focke et al., 2011), which
can cause geometric distortions and signal loss, and influence the effective excitation
field and flip angle, thus affecting contrast in T1-weighted images (Truong et al., 2006).
Inversion time is typically chosen in line with T1-relaxation (and hence field strength) as
it determines the magnetization before excitation in each tissue, and thus the T1-contrast.
Pixel bandwidth, or receiver bandwidth, refers to the difference in magnetic resonance
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frequencies between adjacent pixels. This parameter is most commonly associated with
chemical shift between fat and water and has a direct effect on image SNR (Schmitz et
al., 2005). In the present study, it is difficult to disentangle the effects of individual
parameters due to collinearity. However, it appears likely that the GMC variability
observed in brainstem region is majorly attributable to the inversion time-field strength
interaction.
A second notable scanning effect is observed in IC7. This component highlights the
thalamus region and reflects GMC variability induced by RF coils, especially the
receiving coil. As illustrated in Table 6.1, the majority of the cohorts (1259 out of 1460)
were scanned using the same type of transmitting coil. Therefore, the present data may
not appropriately reflect how transmitting coil influences the image pattern. Moreover,
effects of transmitting coil only become more substantial at 7T or higher (Vaughan et al.,
2001). Regarding the receiving coil, Figure 6.3b shows that subjects scanned with
32-channel head coil exhibit higher GMC in the highlighted thalamus region of IC7.
Meanwhile it is noteworthy that IC7 is the only component associated with SNR (r =
0.26, p = 1.40×10-23). Not surprisingly, SNR exhibits a significant group difference
among different types of receiving coils (p = 3.28×10-46), where 32-channel head coil
yields the highest overall SNR and 8-channel head coil the second. This observation is
consistent with previous studies that have found spatially dependent gains in SNR with
the addition of element coils in multichannel phased-array head coils (de Zwart et al.,
2004; Wintersperger et al., 2006). Overall, our finding reveals interrelationships between
SNR and RF receiving coil, and indicates that coil design may lead to a significant
variability in the image pattern. Given these observations, it is strongly recommended
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that in addition to calibrating magnetic field strength and inversion time, inconsistency in
RF coil designs should also be avoided in aggregated sMRI analyses.
MCIC Data
The second study with the MCIC data confirms significant systematic differences in
the image pattern induced by scanning parameters. The most affected component is IC53,
highlighting inferior temporal region and showing a relationship with scanner and field
strength. It should be noted that magnetic field strength is completely collinear with
sequence, and scanner completely collinear with TR/TE in the MCIC data. Magnetic field
strength, as discussed above, can significantly influence the T1-contrast. The observation
in the MCIC data is consistent with the BIG data in that scans obtained with lower field
strength exhibit higher regional GMC, as shown in Figure 6.5a. Repetition time
determines the recovery of magnetization and directly affects the T1-contrast. The
boxplot with TR/TE (Figure 6.5b) illustrates that MCIC scans acquired with shorter
repetition time exhibit higher regional GMC, consistent with the general concept of
shorter TR leading to higher contrast. In contrast, no linear relation is observed between
the component loadings and TE, suggesting that the observed image variability is more
attributable to repetition time instead of echo time. Although due to collinearity we
cannot determine which parameter is the major contributor to the image variability
observed in IC53, the results confirm that inconsistency in field strength and sequence
design can introduce significant systematic differences in multi-site sMRI studies
(Fennema-Notestine et al., 2007; Stonnington et al., 2008).
IC 53, IC98 and IC7 exhibit association with both scanning parameters and SZ
diagnosis, as shown in Table 6.6 and Table 6.8a. Due to the collinearity, it is impossible
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to accurately estimate the effects of individual parameters. However, IC53 is much more
significantly associated with scanning settings (p = 8.62×10-53, 3.57×10-49, Table 6.6)
than SZ diagnosis (p = 3.00×10-4, Table 6.8), suggesting that the observed variability is
likely more attributable to scanning settings. IC98 highlights the ventricle region, making
the observed SZ effect questionable. IC7 exhibits spatial overlapping with IC9 identified
from the BIG data in brainstem and cerebellum regions. Since IC9 exhibits the most
significant scanning effect in the BIG data, suggesting a high susceptibility to scanning
settings in the region, we incline towards IC7 more likely representing scanning effects
and decide to have it corrected in this study.
After SBM-correction, no significant scanning effects are observed and the SZ effect
is refined when evaluated with ICA, as shown in Table 6.8a. The most significant SZ
effect is observed from IC81, which is spatially consistent with those identified in the
uncorrected (IC94) and GLM-corrected (IC12) data. The component suggests SZ-related
gray matter reduction in a frontal-temporal network, one of the most consistently
identified structural variations in SZ (Cannon et al., 2002; Glahn et al., 2008; Kuperberg
et al., 2003; Turner et al., 2012; Xu et al., 2009). The SBM- and GLM-corrected data
present more significant SZ-effects in the frontal-temporal network compared to the
uncorrected data, suggesting that correcting for confounding effects helps refine the true
effect of interest. Meanwhile, the GLM-corrected data also presents other marginal
effects, as illustrated in Fig 6b. It can be seen that IC15 spatially overlaps with
IC7-uncorrected which has been identified as scanning-related and eliminated in
SBM-correction. IC34 and IC91 reflect sparse and edge effects. In contrast, the
SBM-corrected data presents one single frontal-temporal network exhibiting the most
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significant SZ effect (p = 5.55×10-7), suggesting that the data is more effectively
corrected.
The evaluation with VBM echoes the results obtained with the ICA approach. Both
SBM- and GLM-correction effectively eliminate the scanning effects. On the other hand,
the uncorrected data present more SZ-related voxels than the GLM- and SBM-corrected
data, as illustrated in Table 6.8b. For the GLM-corrected data, the identified 228 voxels
are a subset of the 421 voxels identified in the uncorrected data. The difference is
believed to result from the collinearity among regressors. It is expected that the scanning
parameters capture more of the shared variance when they are modeled alone in the
GLM-correction, leaving less variance for the SZ diagnosis in the subsequent VBM
analysis. For the SBM-corrected data, a side-by-side slice view (Figure 6.7) illustrates
that much fewer voxels are identified in brainstem and cerebellum regions. Clearly, these
voxels are largely captured in the uncorrected data by IC7, which is subsequently
eliminated in the SBM-correction. Therefore, no significant effects are expected in this
region.
The comparison between GLM and SBM correction demonstrates that the former is
more model-based while the latter more data-driven. In a GLM model, all the variances
that can be explained by the predictors are regressed out. As shown in Table 6.8a, the
GLM approach seems eliminating effects from scanner, field strength and slice thickness
more completely than the SBM approach (p-values are higher than those obtained from
the SBM approach although both are not significant). However, one concern is that the
GLM model is not able to deal with embedded collinearity, such that variance shared
between scanning parameters and traits of interest may also be eliminated. In contrast, in
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the SBM model, ICA is able to extract components attributed to different sources. This
particularly manifests in the observation that the SZ effect is split into independent
components (IC94, IC98, IC53 and IC7 in the uncorrected data, see Table 6.8a). While
the GLM approach cannot separate the SZ-related voxels from each other, ICA
acknowledges that they covary with different underlying patterns and extracts meaningful
components. Subsequent analyses suggest that IC94 shows no scanning effects, while
others are likely confounded. Thus, ICA-based SBM model enables the researchers to
recognize the heterogeneity and allows flexibility on whether a correction is necessary for
each component.
In summary, our study explores scanning effects in multi-site sMRI studies and
demonstrates an effective approach for correction. The results suggest that magnetic field
strength and sequence design (including repetition time, inversion time) are likely the
most significant contributors to the image variability, although the individual effects
could not be disentangled in the present data and await more investigations. Another
significant confounder highlighted is RF receiving coil, which needs to be considered in
the current atmosphere of data sharing and aggregation for large-scale analyses. The
second study demonstrates that scanning effects can be isolated from the disease effect
through SBM approach, and a correction could be further applied to refine the true effect
of interest. Overall, consistent field strength, sequence design and RF coil are strongly
recommended for multi-site sMRI studies, though SBM proves a flexible and effective
approach to detect and clean scanning effects, which helps reduce the risk of false
positives.
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CHAPTER 7

GUIDED EXPLORATION OF GENOMIC RISK

FOR GRAY MATTER ABNORMALITIES IN SCHZIOHRENIA

7. 1

Introduction

Schizophrenia (SZ) is a severe psychiatric disorder demonstrating a strong genetic
component with heritability estimated up to 80% based on family and twin studies
(Cardno and Gottesman, 2000). In the past decade, a number of susceptibility genes have
been identified from linkage and association studies (Duan et al., 2010; Harrison and
Owen, 2003). However, the associations between SZ diagnosis and individual
polymorphisms were often weak (Duan et al., 2010). These results suggest a polygenic
model for SZ (Gottesman and Shields, 1967), hypothesizing that multiple alleles with
small individual effects may interact synergistically to increase the susceptibility to the
disorder. The hypothesis is supported by a recent study, demonstrating the involvement
of an aggregate of common (frequency > 0.05) single nucleotide polymorphisms (SNPs),
collectively accounting for a substantial proportion of variation in risk to the disorder
(Purcell et al., 2009b).
In response to the complex genetic architecture underlying SZ, a multivariate
approach is well positioned to examine associations between SZ-related phenotypes and
genetic components derived from various potential susceptibility alleles. Prata et al.,
examining epistasis between DAT and COMT genes, demonstrated that the nonadditive
DAT-COMT interaction was associated with a SZ-altered modulation effect on cortical
function during executive processing (Prata et al., 2009). Expanding the variables to 24
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SNPs spanning 14 SZ putative risk genes, Meda et al. identified two genetic components
(DAT and BDNF; SLC6A4, 5HTTLPR and 5HTTLPR_AG) correlating with three
functional brain networks; the combined brain function-gene effects showed significant
group differences in SZ (Meda et al., 2010). These positive findings have encouraged
researchers to explore more genetic influences, including interactions among known risk
genes and novel genes.
Simultaneously, an allied line of research has focused on defining endophenotypes
given the heterogeneity of symptoms, course and outcome in SZ (Gottesman and Gould,
2003). Some identified endophenotypes are based on magnetic resonance imaging (MRI),
which has demonstrated its specific value in identifying regional brain abnormalities
(Rapoport et al., 2005), including structural endophenotypes (Lawrie et al., 2003;
McDonald et al., 2006; Nelson et al., 1998; Sun et al., 2009) and functional networks
recorded in fMRI that discriminate SZ patients from healthy controls.
In this work, we performed a guided exploration of genomic risk for SZ-related gray
matter abnormalities using the proposed pICA-R approach. Whole-brain gray matter
concentration images were analyzed in conjunction with genome-wide single
nucleotide polymorphisms (SNPs) to investigate the genetic factors possibly
underlying the regional variations in brain structure which relates to clinical
manifestations. In particular, a genetic reference was derived from a previous SZ
genome-wide association study with the largest sample size to guide the data
decomposition such that reliable genetic components emphasizing specific biological
mechanisms can be extracted.

87

Chapter 7 Guided Exploration of Genomic Risk for Gray Matter Abnormalities in
Schizophrenia

7. 2

Materials and Methods

Participants
Structural MRI and SNP data were obtained from The Mind Clinical Imaging
Consortium (MCIC), a collaborative effort of four research teams from University of
New Mexico-Mind Research Network, Massachusetts General Hospital, University of
Minnesota and University of Iowa) and from a local COBRE (Center of Biomedical
Research Excellence) study. The institutional review board at each site approved the
study and all participants provided written informed consents. All healthy participants
were screened to ensure that they were free of any medical, neurological or psychiatric
illnesses, including any history of substance abuse. The inclusion criteria for patients
were based on a diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
confirmed by the Structured Clinical Interview for DSM-IV-TR disorders (SCID, (First et
al., 1997)) or the Comprehensive Assessment of Symptoms and History (CASH,
(Andreasen et al., 1992)). After preprocessing, we obtained a total of 300 participants
(160 healthy controls and 140 SZ patients) for which both sMRI and SNP data were
collected. Table 7.1 provides the demographic information.
Data Collection and Preprocessing
The brain images were T1-weighted MRIs collected from 440 participants at multiple
sites. 1.5T scanners were used at Massachusetts General Hospital (Siemens), University
of New Mexico (Siemens) and University of Iowa (GE), and a 3T scanner was used at
University of Minnesota (Siemens). Imaging parameters for the scans at MGH and New
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Mexico were TR/TE = 12/4.76ms, slice thickness = 1.5mm, bandwidth = 110Hz,
voxelsize
Table 7.1: Demographic information of participants.
Demographics
Sex
Age
Race/Ethnicity

Collection site

Male
Female
Mean ± SD
Range
Caucasian
African American
Asian
Native Hawaiian
American Indian
Unreported
Harvard
Iowa
Minnesota
New Mexico

SZ (140)
106
34
36 ± 12
18 - 63
109
20
5
1
1
4
28
32
30
50

HC (160)
104
56
33 ± 11
18 - 63
140
8
5
0
2
5
24
59
19
58

P-value
0.04
0.03
0.19

0.85

= 0.625 × 0.625×1.5mm. At Iowa the parameters were TR/TE = 20/6ms, slice thickness =
1.6mm, bandwidth = 122Hz, and voxel size = 0.664 × 0.664×1.6mm. At Minnesota the
parameters were TR/TE = 2530/3.81ms, slice thickness = 1.5mm, bandwidth = 110Hz,
voxel size = 0.625 × 0.625×1.5mm (Segall et al., 2009). All scans were collected in a
coronal orientation.
The T1-weighted sMRI data were preprocessed in Statistical Parametric Mapping 5
(SPM5, http://www.fil.ion.ucl.ac.uk/spm) using voxel based morphometry (VBM)
(Ashburner and Friston, 2005), a unified model where image registration, bias correction
and tissue classification are integrated. Brains were segmented into gray matter, white
matter and cerebrospinal fluid based on unmodulated normalized parameters. The
resulting gray matter images consisted of voxelwise gray matter concentrations. Images
were re-sliced to 2 × 2 × 2 mm, resulting in 91 × 109 × 91 voxels. The gray matter
images were then smoothed with 10mm full width at half-maximum Gaussian kernel. In
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the subsequent quality check, we further excluded two participants whose images were
four standard deviations away from the average gray matter image. A mask was then
generated to include only the voxels inside the brain as well as exhibiting an average gray
matter concentration greater than 0.1, resulting in a total of 253,632 voxels. Finally, a
voxel-wise regression analysis was performed at each voxel to eliminate the effects from
age, sex and collection site. The gray matter images corrected for the above variables
were then analyzed in conjunction with the SNP data.
DNA was extracted from blood samples of 255 MCIC participants and saliva samples
of 84 COBRE participants respectively (six participants appeared in both studies).
Genotyping for all participants was performed at the Mind Research Network using the
Illumina Infinium HumanOmni1-Quad assay spanning 1,140,419 SNP loci. BeadStudio
was used to make the final genotype calls. No significant difference was observed in
genotyping call rates between blood and saliva samples.
PLink (Purcell et al., 2007a) was used to perform a series of quality control
procedures. Gender was imputed based on x-chromosome heterozygosity rates and
checked against internal QC files; SNPs and participants were checked for a genotyping
rate of less than 90%; SNPs were excluded if they showed deviation from
Hardy-Weinberg Equilibrium in controls with a threshold of 10-6 or if they failed to be
missing at random with a threshold of 10-10; 4 participant was excluded due to relatedness
with an identity-by-descent value > 0.1875; 2 participants were also excluded with
heterozygosity ratios 3-SD away from the average; minor allele frequency cut-off was set
to 0.01. Discrete numbers were then assigned to the categorical genotypes: 0 for no minor
allele, 1 for one minor allele and 2 for two minor alleles. Subsequently, we replaced the
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missing genotypes using haplotype genotypes of high linkage disequilibrium loci if
available (LD, correlation > 0.80). After the above procedures, 777,365 autosomal SNPs
were retained for MCIC data and 823,733 autosomal SNPs were retained for COBRE
data, resulting in the final dataset of 327 samples × 728,683 common SNPs. It was noted
that the minor allele differed between MCIC and COBRE data for 23,716 SNPs. We then
adjusted the minor allele codings of these 23,716 SNPs in COBRE data to be consistent
with those in MCIC data. Finally, as we decided to admit participants from all ethnic
groups, population stratification was investigated through PCA (Price et al., 2006).
Specifically, the SNP data were decomposed into a linear combination of underlying
components, four of which differed significantly among ethnicities (p = 2.40×10 -99,
1.51×10-85, 1.25×10-30, 1.28×10-18, respectively) while not differentiating between
schizophrenia patients and healthy controls, suggesting weak associations with the
disorder. Therefore, we eliminated these four components from the original data.
Afterwards, a Q-Q plot (Chanock et al., 2007) for p-values of group differences between
patients and controls tested against a uniform distribution showed no clear indication of
population structure (Figure 7.1).

Figure 7.1: Q-Q plot of p-values (two sample t-test, group difference between patients
and controls in terms of MAF) tested against a uniform distribution.
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Association Analysis
Parallel ICA with reference (pICA-R) was used for the association analysis.
Regarding the genetic reference, we leveraged the results from an independent
genome-wide SZ study to obtain genetic references. First, we selected a potential
susceptibility gene ANK3 with intragenic SNPs exhibiting top genome-wide associations
in the Psychiatric Genomics Consortium (PGC) SZ study ((Ripke et al., 2011), Table
S10), which is currently the SZ study with the largest sample size. This gene is involved
in neuronal activities (Lambert et al., 1997; Zhou et al., 1998) and therefore poses a
promising candidate to be a reference in this imaging genetics study. We then identified
the corresponding SNPs in ANK3 and grouped neighboring SNPs with moderate LD (|r|
> 0.5) into a cluster, which could serve as a reference set. The LD threshold was
determined by a visual inspection of our data, while also considering that SNPs with r2 >
0.2 are not considered independent (Ripke et al., 2011). For this proof-of-principle and
method development study, our primary strategy for reference selection was that, in
pICA-R, the reference loci are expected to contribute simultaneously to one single
component, which is the case most likely to happen for SNPs in LD. Therefore, we chose
to use LD clusters as references to elicit more SNPs contributing in a coordinated
manner. Finally we tested three reference sets from ANK3, each spanning more than 40
SNPs, which were to yield at least 20 true loci with an accuracy of 0.5, a reasonable size
as observed in simulations. It should be noted that we only examined a limited number of
references in this work, as the major purpose was to demonstrate an application of the
proposed approach instead of performing a complete SZ study. While there are also other
genes that are of great importance, they will be left for future investigations.
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For the purpose of validating our finding, the SNP component identified by pICA-R
was examined for its SZ enrichment based on the independent results of the PGC SZ
study (Ripke et al., 2011). We first selected out SNPs significantly contributing to the
identified component. Next, we compared the ratios of SZ-related SNPs in the selected
top contributing SNPs and in the whole genome. For each SNP, the SZ-relevance was
determined based on the significance of association reported in the PGC SZ study, such
that a SNP exhibiting SZ association with a p-value less than Pth was considered as
SZ-related. To examine the enrichment across different significance levels, we tested a
Pth range from the standard level of 0.05 to a more significant level of 0.001. Then based
on this criterion of SZ-relevance, we performed Fisher’s exact test to evaluate the
significance of SZ enrichment in our finding compared to the whole genome.
In addition, we applied ICA, pICA and ICA-R to the sMRI-SNP dataset for a
comparison. In case of ICA, we applied two separate regular ICAs to the sMRI and SNP
data respectively. Then pairwise correlations were calculated based on the loadings. In
case of pICA, the dataset were directly analyzed for inter-modality associations. In case
of ICA-R, we applied regular ICA to the sMRI data while ICA-R was used to extract the
SNP component given the same reference. As in pICA-R, the number of components was
selected to be 10 for the sMRI data and 27 for the SNP data, if a component number
estimation applied.

7. 3

Results

The number of components was estimated to be 10 on uncorrelated voxels of the
sMRI data using minimum description length (MDL) (Rissanen, 1978). For the SNP data,
93

Chapter 7 Guided Exploration of Genomic Risk for Gray Matter Abnormalities in
Schizophrenia
27 components were extracted based on the metric of consistency (Chen et al., 2012b).
We tested the three reference sets generated from ANK3 (Ripke et al., 2011), and one
reference set spanning 82 SNPs helped elicit significant inter-modality connection. These
82 SNPs exhibited moderate LD with an average correlation of 0.57 and were separated
by an average of 1,276 base pairs. Guided by this reference, pICA-R identified one
component pair exhibiting the highest correlation of -0.27 and a p-value of 1.64×10-6
(passing Bonferroni correction of 0.05/10/27). After regressing out variables (specifically
age, sex, race/ethnicity, collection site and SZ diagnosis for the SNP component;
race/ethnicity and SZ diagnosis for the sMRI component), the sMRI-SNP association
remained significant, exhibiting a partial correlation of -0.24 (p = 2.81×10-5), as shown in
Figure 7.2.

Figure 7.2: Scatter plots of loading coefficients associated with the identified sMRI and
SNP components in patient and control group respectively. Controlling variables (age,
sex, race/ethnicity, collection site) are corrected.
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The loadings of the linked sMRI component significantly differed between SZ
patients and healthy controls (two tailed t-test, p = 1.33×10-15). Note that effects from
age, sex and collection site were already regressed out from the data and we did not
observe any significant regression (two tailed t-test, p = 0.11) effect from the
race/ethnicity on the sMRI component while controlling for diagnosis. We further
examined whether medication affected the identified brain network in patients and found
no significant regression effect (two-tailed t-test, p = 0.62) from the reported
chlorpromazine equivalent dosage (Gardner et al., 2010) on the sMRI loadings while
controlling for race/ethnicity. Figure 7.3 shows the spatial map of the sMRI component
thresholded at |Z| > 3. The identified brain network included medial and inferior frontal
gyri, superior temporal gyrus, insula and anterior cingulate, as listed in Table 7.2.
Table 7.2: Talairach labels of identified brain regions (|Z| > 3).
Brain region

Brodmann area

L/R volume (cm3)

L/R random effects, max Z (x,y,z)

Medial Frontal Gyrus

9, 10, 6, 8

3.2/1.4

4.21(0,42,22)/3.98(2,49,10)

Inferior Frontal Gyrus

47, 13

2.6/2.8

5.09(-40,17,-14)/5.67(44,13,-9)

Superior Temporal Gyrus

38, 22, 13

2.3/3.8

4.94(-44,17,-13)/5.54(44,13,-11)

Insula

13, 22, 47

0.4/1.8

3.74(-44,9,-6)/5.28(44,9,-7)

Anterior Cingulate

32, 10

0.7/0.3

4.01(0,49,7)/3.86(2,47,9)

Figure 7.3: Spatial map of brain network for the identified sMRI component (|Z| > 3).
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The loadings associated with the linked SNP component exhibited a significant group
difference between patients and controls (two tailed t-test, p = 0.04). The SNP component
followed a super-Gaussian distribution and Figure 7.4 shows a logistic fit to the
histogram. Based on the normalized component weights, we selected out 1,030 top
contributing SNPs (top 1,030 based on the absolute values of the normalized component
weights, corresponding to |Z| > 3.60, p = 0.003 based on the logistic fit, see Figure 7.5) as
our finding.

Figure 7.4: Logistic fit to the identified SNP component.

Figure 7.5: Illustration: how the number of top contributing SNPs is determined. The
blue curve shows the plot of normalized component weights (descending absolute
values); L1 and L2 represent the linear fits to the two segments of the component curve;
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A denotes the intersection of L1 and L2; the green line (L3) represents the line
connecting the origin and the intersection A; B denotes the intersection of L3 and the
component curve.

Figure 7.6: Manhattan plot for the identified SNP component (threshold at |Z| > 3.60 for
top contributing SNPs).
Figure 7.6 shows a Manhattan plot of weights of loci for the identified SNP
component, where clusters spanning more than 10 top contributing SNPs are marked.
Table S1 provides a summary of the identified 1,030 SNPs, including SNP position,
corresponding gene, normalized component weight, and MAFs in patient and control
groups. Fifty-four out of the top 1,030 contributing SNPs were from the reference set and
are marked in Table S1. A complete list of the 82 reference SNPs is also provided in
Table S2. After these 54 reference SNPs were excluded, 656 out of the remaining 976
SNPs had been investigated in the PGC study for associations with SZ. We then
conducted Fisher’s exact test on SZ enrichment between these 656 matched SNPs and the
whole genome of PGC data (spanning a total of 1,252,901 SNPs). As shown in Figure
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7.7, significant SZ enrichment was consistently observed within the entire range of tested
Pth’s.

Figure 7.7: Fisher’s exact test on SZ enrichment between the identified SNPs and the
whole genome based on PGC results. Pth denotes the threshold p-value of SZ-relevance,
ranging from 0.001 to 0.05.
We further investigated biological functions in which these top contributing SNPs are
involved. While 522 out of 1,030 SNPs were mapped to 228 unique genes, Ingenuity
Pathway Analysis (IPA: Ingenuity® Systems, http://www.ingenuity.com) indicated a
significant enrichment of the domain of central nervous system development (p =
2.88×10-4) in our finding, where 7 genes were involved, as highlighted in Table 7.3a. The
identified genes were also significantly overrepresented in glutamate receptor signaling
(p = 2.75×10-2) and DARPP32 regulated pathway (p = 4.07×10-2), as well as synaptic
long term depression (LTD, p = 1.58×10-2) and potentiation (LTP, p = 3.24×10-2), as
highlighted in Table 7.3b. In addition, the DAVID (Database for Annotation,
Visualization and Integrated Discovery) bioinformatics resource (Huang et al., 2009a, b)
identified significant clusters functionally related to cell adhesion (p = 1.14×10-5),
synaptic transmission (p = 2.86×10-4) and neuron projection morphogenesis (p =
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1.75×10-3) respectively, as highlighted in Table 7.3c. The identified canonical pathways
and functional annotation clusters remained highly stable when the number of top
contributing SNPs was adjusted from 1,000 to 5,000, as shown in Table 7.4 and 7.5.

Table 7.3: Biological Pathway analysis and functional annotation clustering.
1a. IPA biological function

Genes

P-value/P-value (B-H)

Coronary disease

ACE, ASIC2, CACNA1C, CERS6, CHRNA5,
CSMD1, CSMD2, ITGB2, MECOM, MGAM,
PPARA, PTPRM, SAMD12
ACE, ASIC2, CACNA1A, CACNA1C, CERS6,
CHRNA5, COL4A1, COL4A2 (includes EG:12827),
CSMD1, CSMD2, ITGB2, MECOM, MGAM,
PPARA, PTPRM, SAMD12, TEK
CMIP, DAPK3, IGF1R, ITGB2, PRKD1

2.24E-05/1.68E-02

ASIC2, CACNA1C, CERS6, CSMD1,
CSMD2, ITGB2, MECOM, MGAM,
PPARA, PTPRM, SAMD12
ADAM22, ASIC2, CNTNAP2, DSCAML1, MYO16,
PARK2, ZBTB16
ACE, ASIC2, CACNA1C, CERS6, CSMD1, CSMD2,
ITGB2, MECOM, MGAM, PPARA, PTPRM, SAMD12

1.20E-04/2.25E-02

1b. IPA Canonical Pathway

Genes

P-value/P-value (B-H)

AMPK Signaling

PFKFB3, AK5, ACACB, PPP2R2C, PFKP, CHRNA5

4.17E-03/7.93E-01

Aldosterone Signaling in Epithelial Cells

DNAJC17, ASIC2, DNAJC18, PLCB1, DNAJC10, PRKD1 9.77E-03/8.08E-01

Synaptic Long Term Depression

IGF1R, PLCB1, PPP2R2C, GRM4, PRKD1

1.58E-02/8.08E-01

Maturity Onset Diabetes of Young
(MODY) Signaling
Glutamate Receptor Signaling

CACNA1C, CACNA1A

2.04E-02/8.08E-01

SLC1A1, GRM4, GNG2

2.75E-02/8.08E-01

Synaptic Long Term Potentiation

CACNA1C, PLCB1, GRM4, PRKD1

3.24E-02/8.08E-01

Vascular disease

Aggregation of tumor cell lines
Coronary artery disease

Development of central nervous system
Atherosclerosis

8.53E-05/2.25E-02

9.70E-05/2.25E-02

2.88E-04/4.31E-02
4.26E-04/5.33E-02

Dopamine-DARPP32 Feedback in cAMP CACNA1C, PLCB1, PPP2R2C, PRKD1, CACNA1A
Signaling
Agrin Interactions at Neuromuscular
ITGB2, NRG3, ARHGEF7
Junction
G Protein Signaling Mediated by Tubby
PLCB1, GNG2

4.07E-02/8.08E-01

RhoGDI Signaling

CDH12, ARHGEF7, CDH10, GNG2,
ARHGAP8/PRR5-ARHGAP8

5.13E-02/8.08E-01

1c. DAVID functional annotation cluster

Genes

P-value/P-value (B-H)

Cell adhesion

PTPRM, CLSTN2, MAGI1, TNC, PCDH9, FBLIM1,
DSCAML1, ITGB2, PTPRT, COL5A1, BTBD9, CDH12,
SEMA5A, PKP2, TEK, PECAM1, CNTNAP2, RELN,
CNTN4, IZUMO1, ADAM22, CDH10
GRM4, ACCN1, DLGAP1, GABRR1, CHRNA5,
PARK2, VIPR1, CACNA1C, KCNIP1, RIMS1,
SLC1A1, CACNA1A
SEMA5A, IGF1R, PTPRM, ANK3, DSCAML1,
CNTN4, RELN, GAS7, CACNA1A

1.14E-05/1.14E-02

Synaptic transmission

Neuron projection morphogenesis

4.37E-02/8.08E-01
5.01E-02/8.08E-01

2.86E-04/9.18E-02

1.75E-03/1.78E-01

Note: P-value(B-H) represents the Benjamini-Hochberg corrected p-value of enrichment.
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Table 7.4: IPA canonical pathways with varying numbers of top contributing SNPs.
IPA canonical
pathway

N = 1000

N = 2000

N = 3000

N = 4000

N = 5000

p/p (B-H)

p/p (B-H)

p/p (B-H)

p/p (B-H)

p/p (B-H)

Synaptic long
term depression

1.58E-02/8.08E-01

4.68E-04/1.29E-01

2.57E-04/2.00E-02

9.33E-05/8.71E-03

2.63E-04/2.57E-02

Glutamate
receptor signaling

2.75E-02/8.08E-01 1.10E-02/6.00E-01 1.20E-02/3.51E-01
GRM5,GRM7,GRIN2B,GRID1,GRM8,SLC1A1,GRM4,GNG2

1.05E-02/1.33E-01

7.94E-03/1.78E-01

Synaptic
long term
potentiation

3.24E-02/8.08E-01

4.17E-05/5.13E-03

1.00E-04/1.32E-02

PRKCQ,GRM8,RYR2,GRM4,GRM7,GRM5,PLCD1,PRKG1,GRID1,PLCG2,PPP2R2B,IGF1R,PLCB1,
PRKCE,PPP2R2C,PRKD3,PRKD1,PRKCB

6.92E-03/6.00E-01

1.66E-04/1.74E-02

GRIN2B,PRKCQ,GRM8,CACNA1C,GRM4,PRKAG1,GRM7,PLCD1,GRM5,PLCG2,PRKAG2,PRKCE,
PLCB1,PRKD3,PRKD1,CAMK2B,PRKCB

Dopamine-ARPP32 4.07E-02/8.08E-01 3.72E-02/7.21E-01 1.07E-03/5.62E-02 5.25E-04/2.45E-02 1.45E-03/6.31E-02
feedback in cAMP
signaling
KCNJ12,GRIN2B,PRKCQ,CACNA1C,CACNA1A,PRKAG1,PLCD1,PRKG1,KCNJ10,PLCG2,PPP2R2B,
PRKAG2,PLCB1,PRKCE,PPP2R2C,PRKD3,PRKD1,PRKCB

Note: N represents the number of top contributing SNPs; p and p(B-H) represent the uncorrected and
Benjamini-Hochberg corrected p-values of enrichment.

Table 7.5: DAVID functional annotation clusters with varying numbers of top SNPs.
N = 1000
DAVID
annotation cluster p/p (B-H)

N = 2000

N = 3000

N = 4000

N = 5000

p/p (B-H)

p/p (B-H)

p/p (B-H)

p/p (B-H)

Cell
adhesion

4.40E-06/2.41E-03

2.64E-06/5.43E-03

1.73E-06/8.53E-04

1.44E-09/3.77E-06

1.14E-05/1.14E-02

NRP2, CLSTN2, OPCML, PCDHGA1, CDH22, WISP1, ROBO1, CNTNAP2, ROBO2, IZUMO1,
DSCAM, SYK, PTPRK, PTPRM, MAGI1, CNTN5, TRPM7, LEF1, PCDH9, FBLIM1, PTPRT, MFGE8,
PTPRU, NRXN1, CERCAM, BTBD9, SLC26A6, PGM5, RELN, CNTN4, DST, DCHS2, GNE, TNC,
DSCAML1, SPOCK1, IL32, ITGB2, SOX9, CDH4, ITGBL1, SEMA5A, FAT3, TNR, COL6A3, TEK,
BAI1, CD2, SSX2IP, COL18A1, BMP1, GMDS, ADAM23, COL13A1, LPP, PPFIBP1, CELSR3, ITGA2,
PCDH15, COL5A1, CDH12, CDH13, COL19A1, PKP2, PKP3, CDH18, FBLN5, PECAM1, ADAM22,
CDH10, NTM, HABP2, MUC16
Synaptic
transmission

2.86E-04/9.18E-02

Neuron projection
or development

1.75E-03/1.78E-01

7.79E-08/1.28E-04

6.31E-06/4.32E-03

8.30E-07/1.02E-03

2.51E-06/5.50E-04

SYT1, KCNC4, CACNB2, VIPR1, RIMS1, KCNIP1, AMPH, KCNQ5, GRIN2B, CHRNA5, SLC1A1,
HTR1F, CHRNA3, KCNMA1, DLGAP1, GABRG3, DLGAP2, NRXN1, PARK2, PARK7, GRM5, GRM4,
ACCN1, GABRR1, NPY, PNOC, GRM8, GRM7, KCNN3, SLC6A5, GHRL, UNC13C, CACNA1C,
UNC13B, CACNA1A
7.99E-05/1.07E-02

2.03E-05/8.34E-03

1.64E-06/1.01E-03

3.69E-07/1.61E-04

DCC, NRP2, NRTN, OPCML, DSCAML1, PRKG1, CDH4, SEMA5A, ATP2B2, IGF1R, ROBO1, ANK3,
TNR, NUMB, BAI1, CNTNAP2, ROBO2, B3GNT2, DSCAM, KLF7, PTPRM, SPTBN4, NTNG1,
CELSR3, NRXN1, LMX1A, FIG4, GAS7, TP73, SLIT3, SLC26A6, CLIC5, MAP2, GHRL, RELN,
CNTN4, EFNA5, DST, NTM, CACNA1A, GFRA3

Note: N represents the number of top contributing SNPs; p and p(B-H) represent the uncorrected and
Benjamini-Hochberg corrected p-values of enrichment.
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Compared to pICA-R, ICA did not identify any significant association between the
two modalities (r = -0.16, p = 6.68×10-3). pICA identified a significant sMRI-SNP
association (r = -0.24, p = 3.13×10-5). After regressing out possibly confounding
variables (age, sex, collection site, ethnicity and diagnosis), the partial correlation was
-0.18 (p = 1.40×10-3). Using the same reference set as in pICA-R, ICA-R did not identify
any significant sMRI-SNP association (r = -0.13, p = 0.03). Given that pICA identified a
significant association, we then performed a cross validation for that SNP component
based on the PGC SZ study, and did not observe any significant SZ enrichment compared
to the whole genome (Figure 7.8). Thus pICA-R was the only approach that identified a
significant sMRI-SNP association and also showed significant SZ enrichment in our
validation study.

Figure 7.8: Fisher’s exact test on SZ enrichment between the SNPs identified by pICA
and the whole genome based on PGC results. pth denotes the threshold p-value of
SZ-relevance, ranging from 0.001 to 0.05.

7. 4

Discussion

Given a sample-to-SNP ratio around 4.12×10-4, pICA-R identified one sMRI-SNP
component pair exhibiting a significant association (r = 0.24, p = 2.81×10-5) while
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controlling for age, sex, race/ethnicity, collection site and SZ diagnosis, indicating that
the association was not mainly attributable to these factors. The loadings associated with
the SNP component differentiated patients from healthy controls (p = 0.04), while the
sMRI loadings showed a more significant group difference (p = 1.33×10 -15). Overall, the
results suggest that the identified genetic factor might underlie a proportion of variation
in gray matter concentration that further contributes to SZ phenotypic symptoms
(Harrison, 1999).
sMRI component: The loadings associated with the sMRI component were
significantly lower in patients, indicating an overall SZ-related loss of gray matter, which
has been indicated in a number of studies (Glahn et al., 2008; Gur et al., 2007; Narr et al.,
2005; van Haren et al., 2007). The identified brain network consisted of dorsolateral
(Brodmann Areas (BA) 9) and ventrolateral (BA6 and 47) prefrontal cortices (DLPFC
and VLPFC), as well as anterior cingulate (BA32) and insular cortex (BA13). This
network overlaps considerably with an SMRI component identified before in these data,
and found to be heritable in a sibling-pair analysis (Turner et al., 2012). DLPFC is
connected to a variety of brain areas and plays an important role in working memory
(WM), executive function and other higher-order cognitive processes. Recent work also
lends support for DLPFC contributing to the encoding of relational memory, which may
further promote long-term memory (LTM) formation, through its role in WM
organization (Blumenfeld et al., 2011; Murray and Ranganath, 2007). VLPFC, compared
with DLPFC, is generally considered as involved in LTM formation, where the left
frontal region is more associated with verbal memory while the non-verbal memory
activates more of the right frontal region (Buckner et al., 1999). The anterior cingulate
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(BA32) consists of affective and cognitive subdivisions, the former more associated with
emotional processes and the latter more activated by tasks requiring cognitive and
attentional control (Davidson et al., 2002; Pizzagalli, 2011). The above highlighted
regions have been consistently reported to be altered in SZ patients, including reductions
in gray matter and cortical thickness (Cannon et al., 2002; Glahn et al., 2008; Kuperberg
et al., 2003; Shenton et al., 2001; Xu et al., 2008), as well as exhibiting abnormal
task-related functional activation (Glahn et al., 2005; Manoach, 2002; Minzenberg et al.,
2009). Overall, our findings are in line with a considerable evidence of gray matter
abnormalities in prefrontal and temporal regions as one of the characteristic deficits in
SZ.
SNP reference: In this work, we adopted the most straightforward strategy to generate
a reference set based on LD clusters of one single gene (ANK3). Genome-wide
association study (GWAS) is based on the premise that a causal variant is located on a
haplotype, and thus a marker allele in LD with the causal variant should show (by proxy)
an association with the trait of interest (Stranger et al., 2011). Therefore, SNPs in one LD
cluster are more likely to contribute simultaneously to one single component and serve as
good candidates for reference.
Although the SNP highlighted in the PGC study (rs10994359 from ANK3) is not
covered in our data, the nearest SNP (rs10761503, 307bp upstream, in LD with
rs10994359 with a D-prime of 1 according to the HapMap CEU LD data) is in moderate
LD with the reference set (exhibiting a mean correlation of 0.43). In addition, we mapped
the selected reference SNPs to the PGC data. 18 out of the 82 reference SNPs were
investigated in the PGC study, and 12 were implicated for SZ relevance (p < 0.05),
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leading to a true causal loci ratio of 0.67 (12/18). Given that the 18 PGC-mapped SNPs
were uniformly distributed along the 82 reference SNPs, this ratio of 0.67 provided a
reference for estimating the number of true casual loci in our reference set, which should
be about 55 (0.67*82). In fact, our results did echo this true causal loci ratio, where 54
out of the 82 reference SNPs were identified as top-contributing. The 54 identified SNPs
included 9 PGC-implicated causal loci, and the remaining 45 SNPs demonstrated very
high LD with the PGC findings. According to the HapMap CEU LD data, 16 SNPs are in
complete LD with the 12 PGC-implicated SNPs (D-prime = 1), and another 4
demonstrate a D-prime of 0.871, 0.875, 0.939 and 0.883, respectively. For other 25 SNPs
not covered in the HapMap CEU LD data, we evaluated in our data their relations with
the 12 PGC-implicated SNPs and found high correlations (r > 0.96) except for one locus.
These observations suggest that LD can provide good guidance in reference selection.
When limited causal loci are known, searching clusters of SNPs exhibiting LD with them
may be the most effective approach to generate a testable reference in this pICA-R
model.
SNP component: The SNP component was significantly associated with the sMRI
component. On average, SZ patients carried higher loadings on the SNP component while
exhibiting lower gray matter concentration in the identified regions of the sMRI
component. The SNP component was predominantly contributed to by 1,030 SNPs
exhibiting top component weights. Cross-evaluation based on PGC results confirmed that
the top contributing SNPs were significantly overrepresented in terms of SZ-relevance,
which validated our finding. It is noted that when the threshold of SZ-relevance (Pth)
increased, the enrichment diminished, which is reasonable. The top contributing SNPs
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comprised a number of clusters distributed across the whole genome, which is not
surprising given our model, where SNPs in LDs would exhibit comparable effects.
Clusters spanning more than 10 top contributing SNPs are highlighted in Figure 7.6 and
marked by the corresponding cytogenetic bands, some of which have been implicated in
previous studies, such as 5q15 for bipolar disorder (Scott et al., 2009), 15q15.1 for
attention deficit/hyperactivity disorder (Bakker et al., 2003), as well as 17q23.3 for
autism (Girirajan et al., 2011) and schizophrenia (Wahlbeck et al., 2000).
Among the 1,030 top contributing SNPs, 522 reside in a total of 228 unique genes.
The remaining 508 intergenic SNPs lie within sequences not presently annotated but they
could have a regulatory function on large non-coding RNAs and other regulatory
non-coding RNAs.
Pathway analyses of the 228 known genes revealed that they participate in a number
of neurotransmitter and nervous signaling pathways, including glutamate receptor
signaling and DARPP32 regulated pathway, as well as synaptic LTP and LTD. It was
noted that some pathways and clusters were no longer significant after the Benjamini–
Hochberg correction; however this does not necessarily indicate a false positive finding.
First, the correction was performed for all candidate pathways, which may not be
independent from each other, indicating a possibility of over-correction. Second, the
identified canonical pathways and functional annotation clusters remained highly stable
when we adjusted the number of top contributing SNPs from 1,000 to 5,000. In
particular, the enrichment became significant even after the correction at some point
(Table 7.4 and 7.5). Finally, as emphasized by IPA, the enrichment score simply provides
guidance for interpretation, and it is more important to further explore the functions of
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involved genes to interpret the finding. In this study, the pathway analyses results are
provided to help unravel the genetic architecture. The involved genes are discussed in
more details to understand the biological connections between the identified component
and the disorder.
Glutamate receptor signaling (SLC1A1, GRM4, GNG2): Glutamate receptor signaling
plays a crucial role in neurocognitive processes and aberrant glutamate neurotransmission
may be associated with positive and negative symptoms as well as cognitive deficits in
SZ (Coyle, 2006; Egan et al., 2004; Krystal et al., 2010). Recent work also provides
evidence for an association between perturbed glutamate function and gray matter
volume variation in prodromal SZ (Stone et al., 2009). In particular, one SNP in GNG2
(encoding guanine nucleotide-binding protein, gamma-2) has been identified, with its
minor allele relating to an increased gray matter volume in medial prefrontal cortex
(Chavarria-Siles et al., 2012). Also, some glutamate transporters including SLC1A1
(encoding excitatory amino-acid transporter 3) are believed to have pivotal functions in
mediating neurotoxicity, which raises the possibility of underlying structural changes in
SZ (Deutsch et al., 2001; Olney and Farber, 1995). In our finding, three SNPs contributed
to the glutamate pathway, including rs 150195_A (SLC1A1, ‘A’ denotes the minor
allele), rs1873249_G (GRM4) and rs10150721_G (GNG2). The first SNP contributed
with a positive weight, indicating an increased MAF being associated with lower gray
matter concentration; and the latter two SNPs presented negative weights, implying gray
matter loss being associated with decreased MAFs.
Dopamine-DARPP32 signaling (CACNA1A, CACNA1C,

PLCB1, PPP2R2C,

PRKD1): These proteins modulate dopamine and DARPP32 regulated gene expression
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and function, which likely influences synaptic plasticity such as LTP and LTD (Jay,
2003; Svenningsson et al., 2004) as well as being associated with SZ risk (Albert et al.,
2002; Howes and Kapur, 2009). In our finding, five genes are involved in this pathway,
including CACNA1A (rs4926278_C and rs4926279_C), CACNA1C (rs2238070_T),
PLCB1 (rs2745764_T), PPP2R2C (rs7688267_G) and PRKD1 (rs12883327_T).
CACNA1C is likely a major risk gene for bipolar disorder (Ferreira et al., 2008).
Meanwhile, it is of particulate interest that CACNA1A and CACNA1C (calcium
channels, voltage-dependent) also participate in calcium signaling, which plays an
important role in neuronal processes (Lidow, 2003; Mattson, 1992) and may also
contribute to the reduction in neuronal number given its suggested role in cell death
(Sastry and Rao, 2000; Toescu, 1998).
Synaptic LTP and LTD (IGF1R, PLCB1, PPP2R2C, GRM4, PRKD1, CACNA1C):
synaptic LTP and LTD are two forms of synaptic plasticity resulting in altered synaptic
strength, which underlie learning and memory (Collingridge et al., 2010; Cooke and
Bliss, 2006; Linden and Connor, 1995). While learning and memory impairments are
well documented in SZ (Aleman et al., 1999; Paulsen et al., 1995), direct evidence has
also been provided for disrupted LTP/LTD in SZ (Frantseva et al., 2008; Weng et al.,
2011). In our finding, three genes are involved in both LTD and LTP processes, including
PLCB1, GRM4 and PRKD1. GRM4 (encoding metabotropic glutamate receptor 4) is
also implicated in glutamate signaling, while PLCB1 (1-phosphatidylinositol 4,
5-bisphosphate phosphodiesterase beta-1), PRKD1 (Serine/threonine-protein kinase D1)
and PPP2R2C (Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B
gamma isoform) are also implicated in DARPP32 regulated pathway, indicating a
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possible convergence in pathology. On the other hand, IGF1R (Insulin-like growth factor
1 receptor, rs8038015_C and rs6598542_G) is involved only in LTD, where both of two
SNPs contributed with positive weights.
Besides those genes implicated in the aforementioned neurotransmitter and nervous
signaling pathways, it is noteworthy that a number of the remaining detected genes have
been implicated in other neuronal processes. For instance, CNTNAP2 (encoding
contactin-associated protein-like 2) and RELN (encoding reelin), as reported by DAVID,
are among the functional cluster of cell adhesion, which plays an important role in brain
development (Edelman, 1983; Rutishauser and Jessell, 1988). CNTNAP2 is shown to
mediate intercellular interactions during latter phases of neuroblast migration and laminar
organization (Strauss et al., 2006). This gene exhibits a high expression in anterior
temporal and prefrontal regions in humans, yet low or absent expression in rodents
(Abrahams et al., 2007), suggesting a possible role in higher cognitive functions such as
language (Vernes et al., 2008). RELN is suggested to regulate neurogenesis and
migration, as well as enhance synaptic LTP (Hoe et al., 2009; Pujadas et al., 2010;
Spalice et al., 2009). In addition, RELN mutations have been associated with SZ
(Guidotti and Di-Giorgi-Gerevini, 2002; Wedenoja et al., 2008).
It’s noted that IPA indicates an enrichment of coronary artery and vascular disease in
the identified component, as shown in Table 7.3a. While comorbidity between these
diseases and SZ has been documented, most of the previous works highlighted
environmental factors, such as cigarette smoking and metabolic syndrome (Hennekens et
al., 2005; Jeste et al., 1996). This issue may deserve further investigation.
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Combining the sMRI and SNP findings, pICA-R revealed an association between one
genetic component and SZ-related reduction in gray matter concentration in distributed
brain regions. The identified brain regions are among those shown to exhibit gray matter
deficits partly attributable to genetic factors (Cannon et al., 2002; Thompson et al., 2001).
The genetic component reflects enrichment in neuronal processes. It is noteworthy that
both genetic and imaging findings show a particular relevance to cognition, especially
memory function. While the underlying mechanism remains to be elucidated, our finding
strongly suggests that the identified genetic component may affect neurobiological
conditions that play a role in the cognitive deficits of SZ.
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CREB-BDNF

GUIDED

EXPLORATION

OF

GENOMIC RISK FOR CUE-ELICITED HYPERACTIVATION IN
ALCOHOL DEPENDENCE

8. 1

Introduction

Alcohol addiction is a prevalent devastating disease. It is estimated that ~14% of
alcohol users experience dependence, presenting a substantial healthy and economic issue
(Grant et al., 2001). Genetic factors have been shown to affect liability to alcohol
dependence, with the heritability estimated to be 40-80 % while the remainder variances
might be majorly attributable to environmental factors (Heath et al., 1997; Knopik et al.,
2004; Uhl, 2004). Great efforts have been made towards unraveling the genetic etiology
of alcoholism. Targeted gene and large-scale genome-wide studies have provided
evidences for a number of susceptibility variants, highlighting genes involved in a variety
of neural signaling pathways, including dopaminergic (Conner et al., 2005; Filbey et al.,
2008c; Noble, 2000), glutamatergic (Krystal et al., 2003; Mayfield et al., 2008;
Schumann et al., 2008) and GABAergic (Bierut et al., 2010; Enoch et al., 2009; Radel et
al., 2005) systems. Genes encoding alcohol dehydrogenase (ADH) enzymes playing a
key role in alcohol metabolism are also implicated in the vulnerability (Edenberg and
Foroud, 2006; Luo et al., 2007).
Despite the growing knowledge on susceptibility loci contributing to the individual
differences in drinking behavior, the genetic findings in general suffer small effect sizes.
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For instance, in a large genome-wide association study of alcohol dependence where
thousands of subjects were included for investigations, no SNP could pass the
genome-wide significance threshold of 5×10-8 (Stranger et al., 2011). Instead the
highlighted 15 SNPs yielded suggestive associations with p < 10-5 (Bierut et al., 2010),
yet none of them could be replicated in two independence studies with nominal threshold
of 0.05, and nor did they replicate findings of a previous GWAS (Treutlein et al., 2010).
This is essentially a common challenge in complex genetic trait mapping. Like many
other complex disorders, addiction is also suggested as polygenic (Enoch and Goldman,
1999; Goldman, 1993; Johnson et al., 2006), such that the underlying genetic factor
involves many loci with small individual effect sizes. The interpretation of genetic effect
becomes even more complicated due to heterogeneity with different genetic variants
exert influences on phenotypes through different biological mechanisms (Pickens et al.,
1991; Wong and Schumann, 2008).
In this work, we employ parallel ICA with multiple references for the investigation of
genetic effect on alcohol dependence. The multivariate approach assesses many variables
for aggregate effects, posing a promising model for polygenicity. In addition, prior
knowledge is incorporated to guide the data decomposition, such that genetic factors of
specific attributes can be elicited from high-dimensional complex data. Furthermore,
instead of directly linking genetic factors to behavioral assessments, the associations with
neurobiological traits are emphasized. Specifically, brain activations were measured from
subjects exposed to the taste of alcohol which has been shown to appropriately draw forth
altered functions related to alcohol abuse (Myrick et al., 2008; Tapert et al., 2004). Thus,
the approach provides a three-way translational framework for exploring the genetic
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underpinnings of neuronal functions, which might ultimately lead to clinical
manifestations of the disorder.

8. 2

Materials and Methods

Participants
A total of 326 subjects participated in the study to investigate genetic and
neurobiological traits in heavy drinking (Claus et al., 2011). The institutional review
board approved the study. All the participants were recruited from the greater
Albuquerque metropolitan region and provided written informed consents. The inclusion
criterion was based on alcohol consumption, requiring participants to have at least 5 (for
men) or 4 (for women) drinks per drinking occasion at least five times in the past month.
The exclusion criteria included a history of severe alcohol withdrawal, brain-related
medical problems, or symptoms of psychosis. In addition, participants were required to
be sober during the data collection, with a breath alcohol concentration of 0.00. After
preprocessing, 315 participants were admitted into the analysis, for which good quality
fMRI and SNP data were collected. Table 8.1 provides the demographic information.
Table 8.1: Demographic information of participants.
Number of participants

Male (220)

Female (95)

Race/Ethnicity

99
4
2
54
13
47
1
31.74 ± 9.43
21 – 56

43
2
0
28
3
19
0
32.52 ± 10.58
21 – 55

Age

Caucasian
African American
Asian
Latino
Native American
Mixed
Unreported
Mean ± SD
Range
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Table 8.2: Alcohol dependence assessment.
Assessment

Sub-category

Description

ADS

ADS-con
ADS-obs
ADS-per
ADS-phy
ADS-tot
AUDIT-1
AUDIT-2
AUDIT-3
AUDIT-4

Loss of behavior control
Obsessive drinking style
Psychoperceptual withdrawal
Psychophysical withdrawal
Total ADS
How often do you have a drink containing alcohol?
How many drinks do you have on a typical day when you are drinking?
How often do you have 6 or more drinks on one occasion?
How often during the last year have you found that you were unable to
stop drinking once you had started?
How often during the last year have you failed to do what was
normally expected from you because of drinking?
How often during the last year have you needed a first drink in the
morning to get yourself going after a heavy drinking session?
How often during the last year have you had a feeling of guilt or
remorse after drinking?
How often during the last year have you been unable to remember
what happened the night before because you had been drinking?
Have you or someone else been injured as the result of your drinking?
Has a relative, friend, or a doctor or other health worker been
concerned about your drinking or suggested you cut down?
Total AUDIT score
Alcohol consumption total (sum of AUDIT-1, -2, and -3)
Alcohol dependence total (sum of AUDIT-4, -5, and -6)
Alcohol problems total (sum of AUDIT-7, -8, -9 and -10)
Total ICS
Attempted control
Failed control
Percieved control
Past alcohol abuse symptom count
Current alcohol abuse symptom count
Past alcohol dependence symptom count
Current alcohol dependence symptom count
Probable age that regular drinking first occurred
Probable number of years of regular drinking
Probable age of first drink
Number of days since last drink from Time-Line Follow-Back
Total early stress for ages before 19 (0-18 years old)
Early Stress total (all ages reported)
Total Beck Depression Inventory

AUDIT

AUDIT-5
AUDIT-6
AUDIT-7
AUDIT-8
AUDIT-9
AUDIT-10
AUDIT-tot
AUDIT-consump
AUDIT-dep
AUDIT-probs
ICS
ICS-total
ICS-ac
ICS-fc
ICS-pc
Alcohol symptom count PA-count
CA-count
PD-count
CD-count
Drinking history
NewAgeDrink
NewYearsDrink
AgeFirstDrink
LastDrink
Stress
EStress-tot
Stress-tot
BDI-tot

Data Collection and Preprocessing
Behavioral assessment: The assessment was administered through a variety of
questionnaires, including the Alcohol Dependence Scale (ADS) (Skinner and Horn,
1984), the Alcohol Use Disorder Identification Test (AUDIT) (Babor et al., 2001) and the
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Failed Control Subscale of Impaired Control Scale (ICS) (Heather et al., 1998; Heather et
al., 1993). We excluded those relatively incomplete measurements where data were
missing for more than 25 subjects. Finally a total of 34 related behavioral measurements
were used in the subsequent analysis, as listed in Table 8.2. The missing ratio was no
greater than 4/315. It should be noted that most of these behavioral assessments showed
significant associations with age, except for AUDIT-9, AgeFirstDrink, LastDrink,
EStress-tot and Stress-tot.
Functional MRI: Brain activation data were collected during an alcohol craving task
(Claus et al., 2011; Filbey et al., 2008a). Participants were exposed to small amounts of
alcoholic (subjects preferred) or juice (litchi) beverages pseudorandomly presented to
them during the MRI scans. Figure 8.1 shows the schematic of a single taste cue trial.
Each trial sequentially consisted of a s “Ready” prompt, a 24s taste cue presentation and
a 16s washout period. During the cue presentation, participants tasted the presented
beverage (second 1-10 and 12-22) and then swallowed (second 10-12 and 22-24). No
stimuli were presented during the washout and participants viewed the word “Rest”. Two
9min runs were conducted for each participant, with a single run spanning 12 trials, 6 for
each tastant. A 3T Siemens Trio was used for the data collection. The echo-planar
gradient-echo pulse sequence was configured as follows: TR = 2s, TE = 29ms, flip angle
= 75°, voxel size = 3.75mm × 3.75mm × 4.55mm. The collected fMRI data were
preprocessed with FSL ((Smith et al., 2004), http://www.fmrib.ox.ac.uk/fsl/). Standard
motion correction was performed and images were normalized to the Montreal
Neurological Institute (MNI) template (Jenkinson et al., 2002). An 8mm full-width
half-maximum Gaussian kernel was used for spatial smoothing. Finally alcohol versus
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juice contrast images spanning a total of 54,937 voxels were extracted for subsequent
association analyses.

Figure 8.1: Schematic of a single taste cue trial (Filbey et al., 2008a).
SNP data: Saliva samples were collected from participants for DNA extraction.
Genotyping for all participants was performed at the Mind Research Network using the
Illumina Infinium Human 1M-Duo assay spanning 1,199,187 SNP loci. BeadStudio was
used to make the final genotype calls. PLink (Purcell et al., 2007a) was used to perform a
series of quality control procedures as described in the previous chapter for the MCIC
and COBRE data. Specifically, SNPs and participants were first examined for a
genotyping rate threshold of 95%; SNPs were excluded if they showed deviation from
Hardy-Weinberg Equilibrium with a threshold of 10-6 or if they failed to be missing at
random with a threshold of 10-10; 2 participants were excluded due to high heterozygosity
(3-SD greater than the mean across all subjects); Another 2 participants were excluded
due to relatedness with an identity-by-descent value > 0.1875; Minor allele frequency
cut-off was set to 0.01. After the standard quality control, discrete numbers were then
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assigned to the categorical genotypes: 0 for no minor allele, 1 for one minor allele and 2
for two minor alleles. Subsequently, we replaced the missing genotypes using haplotype
genotypes of high LD loci if available (correlation > 0.80). After the above procedures,
missing genotypes were still observed in 123,159 out of a total of 735,938 autosomal
SNPs. We then excluded 18,809 SNPs with a missing ratio greater than 1% and saved the
rest through replacing the missing genotypes using the major alleles of individual loci.
The resulting data spanning 717,129 autosomal SNPs were then investigated for
population stratification using PCA (Price et al., 2006), as we decided to admit
participants from all ethnic groups. Specifically, the SNP data were decomposed into a
linear combination of underlying PCs, three of which (PC1, 2, and 4) differed
significantly among ethnicities (p = 9.85×10-79, 3.23×10-86, 3.21×10-55, respectively)
while exhibiting no association with alcohol dependence. These three components were
then eliminated from the original data. Afterwards, a Q-Q plot (Chanock et al., 2007) for
p-values of AUDIT associations tested against a uniform distribution showed no clear
indication of population structure (Figure 8.2).

Figure 8.2: Q-Q plot of p-values (correlation test between SNP and AUDIT-tot) tested
against a uniform distribution.
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Association Analysis
The fMRI contrast images were analyzed in conjunction with the SNP data using
parallel ICA with multiple references. The number of fMRI components was estimated
by minimum description length (MDL) (Rissanen, 1978) on uncorrelated voxels. The
number of SNP components was estimated based on the metric of consistency (Chen et
al., 2012b). With respect to genetic references, hotspots or pathways harboring
susceptibility genes implicated in previous studies were recruited, as listed in Table 8.3.
The gene cluster CHRNA3-CHRNA5-CHRNB4 is the most replicated finding for
nicotine dependence (Bierut, 2010; Caporaso et al., 2009) while also implicated in risk of
alcohol dependence (Wang et al., 2009). SNPs in 4p12 hosting GABA receptors were
shown to present moderate odds ratios in a GWAS on alcohol dependence (Bierut et al.,
2010) and independent contributions from individual receptors have been suggested.
Another cluster of GABA receptors resides in 5q34. Both mouse and human studies
provided evidences for their modulatory roles in alcohol dependence (Radel et al., 2005).
Alcohol dehydrogenase (ADH) is a primary enzyme involved in alcohol dependence and
variants in the investigated gene cluster, ADH1A-ADH1B-ADH1C have been found
associated with risk of alcoholism (Edenberg and Foroud, 2006; Luo et al., 2007). The
opioidergic system is considered as mediating drug-induced feelings and playing an
important role in substance rewarding properties (Gianoulakis, 2001). Related
polymorphisms have been identified as associated with alcohol dependence (Filbey et al.,
2008b; Zhang et al., 2008). CREB is a key transcriptional factor for neuronal growth and
regulates the expression of BDNF. These two genes have been found to interact in a

117

Chapter8 CREB-BDNF Guided Exploration of Genomic Risk for Cue-Elicited
Hyperactivation in Alcohol Dependence
variety of brain regions and play a critical role in addiction (Carlezon et al., 2005; Crews
et al., 2007; Pandey, 2003).
Table 8.3: Tested genetic references.
Reference

Genes

Evidence

15q24-25
4p12
5q34
4q23
Opioid system
CREB-BDNF

CHRNA3, CHRNA5, CHRNB4
GABRA4, GABRA2, GABRG1, GABRB1
GABRB2, GABRA6, GABRA1, GABRG2
ADH1A, ADH1B, ADH1C
OPRM1, OPRK1, OPRD1
CREB1, CREB5, BDNF

Bierut, 2010; Caporaso et al., 2009; Wang et al., 2009
Bierut et al., 2010; Enoch et al., 2009
Radel et al., 2005
Edenberg et al., 2006; Luo et al., 2007
Filbey et al., 2008; Zhang et al., 2008
Carlezon et al., 2005; Crews et al., 2007; Pandey, 2003

Following the design of parallel ICA with multiple references, we tested each of these
hotspots or pathways separately, where each produced multiple referential SNP sets.
Specifically, for each hotpot or pathway, a reference matrix was generated with each row
representing a reference vector highlighting a group of SNP loci selected from a single
gene. In this study, most of the referential genes spanned tens of SNPs forming a single
LD block, which were directly used to generate a reference vector. One exception was
CREB5 hosting 228 SNPs, for which multiple LD blocks were identified (neighboring
SNPs with moderate LD |r| > 0.5). The LD threshold was determined by a visual
inspection of our data, and also considering that SNPs with r2 > 0.2 are not considered
independent (Ripke et al., 2011). The CREB5 referential set was then derived from each
LD block and combined with the referential sets derived from BDNF and CREB1 to from
the reference matrix. It should be noted that we only examined a limited number of
hotspots and pathways in this work. While there are also other pathways such as
dopaminergic and glutamatergic systems that are of great importance, they will be left for
future investigations.
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To assess the fidelity of the identified association, we applied a subset evaluation test.
Ten runs, each with 90% of the subjects, were conducted for the evaluation of association,
and the fMRI-SNP association identified in the full dataset was tested for its replication
in the subset results. More informatively, we performed a permutation test to assess the
validity of the identified fMRI-SNP association, that is, to investigate the possibility of
the identified association occurring in randomly rearranged subjects. Given the estimated
numbers of components, parallel ICA with multiple references extracted 165 fMRI-SNP
component pairs in each of the 1,000 permutations. We then calculated the tail
probability to evaluate the significance level of the identified fMRI-SNP association
based on the top linked component pair of each run.
The identified linked fMRI-SNP components were further investigated for
connections with behavioral assessments (Table 8.2) to confirm the functional influences.
Partial correlation or regression analysis was conducted to evaluate the association while
controlling for sex and race/ethnicity. False discovery rate (FDR) was applied to correct
for multiple comparisons given the associations among most of the behavioral
measurements. Due to the collinearity, age was not included as a covariate as it is
impossible to isolate its contribution from those of phenotypes.

8. 3

Results

The numbers of components was estimated to be 15 and 11 for the fMRI and SNP
data, respectively. Among the tested hotspots or pathways listed in Table 8.3, three
referential SNP sets derived from the CREB-BDNF pathway were identified as
contributing to the same genetic component, which showed a significant correlation with
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an fMRI component (r = -0.38, p = 3.98×10-12, passing Bonferroni correction of
0.05/15/11). Table 8.4 summarizes the recruited referential loci, which consisted of all
the genotyped loci in BDNF (15 SNPs) and CREB1 (20 SNPs), and an LD block
spanning 20 SNPs in CREB5. After regressing out controlling variables (age, sex,
race/ethnicity), the fMRI-SNP association remained significant, exhibiting a partial
correlation of -0.36 (p = 2.98×10-11), as shown in Figure 8.3a.
Table 8.4: Recruited reference SNPs for the CREB-BDNF pathway.
Gene

SNP

Chr

Position

BDNF

rs1519480
rs7124442
rs6265
rs11030104
rs12291063
rs11030108
rs7103411
rs10835211
rs1013402
rs7127507
rs11030119
rs2030323
rs7934165
rs962369
rs12273363
rs889895
rs2551640
rs2551641
rs2709356
rs2709357
rs2551642
rs11904814
rs6740584
rs2551921
rs2709387
rs2254137
rs2551645
rs2464978
rs13029936
rs2551928
rs1045780
rs6785
rs2551929
rs2256941
rs2551931
rs160337
rs160338
rs1008262
rs310353
rs310361

11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
7
7
7
7
7

27632288
27633617
27636492
27641093
27650677
27652040
27656701
27657941
27668957
27671460
27684678
27685115
27688559
27690996
27701435
208107174
208116138
208118512
208120337
208120777
208121742
208135043
208137596
208143800
208150340
208152273
208159033
208166163
208173789
208174023
208175395
208176242
208176717
208177429
208179725
28594314
28594727
28602266
28603649
28607509

CREB1

CREB5
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rs13233942
rs310338
rs41273
rs1637457
rs17156919
rs41276
rs160375
rs917275
rs160342
rs160343
rs41295
rs160357
rs41298
rs160359
rs41305

7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

28607958
28609570
28611382
28615963
28616653
28616788
28621226
28625047
28630355
28632292
28633161
28635027
28635305
28635520
28640066

Figure 8.3: Scatter plots of: (a) the fMRI and SNP loadings; (b) the fMRI loading and
CD-count; (c) the SNP loading and AUDIT-4.

Figure 8.4: Spatial map of brain network for the identified fMRI component (|Z| > 2).
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Table 8.5: Talairach labels of identified brain regions (|Z| > 2).
Brain region

Brodmann area

L/R volume (cm3)

L/R random effects, max Z (x,y,z)

Precuneus
Superior Parietal Lobule
Postcentral Gyrus
Inferior Parietal Lobule
Cuneus
Paracentral Lobule
Posterior Cingulate

7, 19, 39, 31
7, 5
7, 5, 3, 2, 40, 1
40, 7, 39
19, 18, 7, 30
5, 4, 6, 7
29, 30, 23

16.8/14.1
8.9/7.6
5.3/4.5
3.5/3.5
2.7/3.7
2.9/1.8
1.6/1.0

9.18(0,-58,61)/9.41(3,-58,64)
8.55(-3,-67,56)/8.72(6,-64,58)
8.06(0,-46,66)/9.03(3,-52,66)
4.28(-39,-49,61)/5.11(39,-52,58)
4.53(0,-82,40)/4.59(27,-83,37)
7.28(0,-46,63)/5.71(3,-37,68)
3.25(-6,-41,5)/2.99(6,-41,5)

The identified fMRI-SNP pair was replicated in all subset evaluations, where we
observed stable fMRI-SNP correlations ranging from 0.23 to 0.33 with a median of 0.27
in the 10 subset evaluations. More importantly, in the 1000-run permutation, the top
linked component pair of each run exhibited an fMRI-SNP correlation ranging from 0.11
to 0.38 with a median of 0.16 (absolute values). Only one permuted sample yielded an
fMRI-SNP association higher than that observed in the original data, resulting in a
significant p-value of 0.001 (1/1000) for the identified association (r = -0.38).
The linked fMRI component, after FDR control, was found significantly associated
with a number of behavioral assessments, including CD-count, ICS-fc, and AUDIT-4.
The most significant association was observed from CD-count, exhibiting a partial
correlation of 0.25 (p = 7.04×10-06) after regressing out sex and race/ethnicity, as shown
in Figure 8.3b. In addition, the partial correlation remained significant (r = 0.19, p =
6.45×10-04) after age was further regressed out, suggesting that the observed altered
activation might be more related to current dependence symptoms than alcohol use
history. The fMRI loadings also showed significant associations with ICS-fc and
AUDIT-4 (correlations of 0.24 and 0.21, respectively), where both measures were highly
correlated with CD-count (correlations of 0.68 and 0.76, respectively). Due to this
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collinearity, the individual effect could not be disentangled and we chose to focus on the
most significantly linked symptom CD-count in the following discussion. Figure 8.4
shows the spatial map of the identified fMRI component thresholded at |Z| > 2. The brain
network included precuneus, superior and inferior parietal lobules, as well as postcentral
gyrus, as listed in Table 8.5.
The linked SNP component, with FDR control, exhibited a significant partial
correlation with one single behavioral assessment AUDIT-4 (r = -0.21, p = 1.57×10-04)
after regressing out sex and race/ethnicity, as shown in Figure 8.3c. Again this
association might be majorly attributable to current drinking behavior, given that a
significant partial correlation (r = -0.18, p = 1.05×10-03) was still observed after further
regressing out age. Figure 8.5 demonstrates that 2,020 top contributing SNPs were
selected out based on the absolute values of the normalized component weights using the
same approach as introduced in section 7.3. Figure 8.6 shows a Manhattan plot of
weights of loci for the identified SNP component, where clusters spanning more than 15
top contributing SNPs are marked. Table S3 provides a summary of all the identified
SNPs, including SNP position, corresponding gene and normalized component weight.
While 1,019 out of 2,020 SNPs were mapped to 457 unique genes, Ingenuity Pathway
Analysis (IPA: Ingenuity® Systems, http://www.ingenuity.com) indicated a significant
enrichment of neurological diseases in our finding, including bipolar disorder
(7.56×10-4), schizophrenia (5.50×10-3) and major depression (4.37×10-2), as highlighted
in Table 8.6a. The identified genes were also significantly overrepresented in
neuritogenesis (2.81×10-4) and other developmental functions, as listed in Table 8.6b.
IPA also revealed a number of enriched canonical pathways, including synaptic long term
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depression (LTD, 1.70×10-5) and potentiation (LTP, 5.89×10-3), CREB Signaling in
Neurons (6.31×10-4), protein kinase A (PKA) signaling (1.26×10-2), as well as GABA
receptor signaling (2.24×10-2). Table 8.6c provides a complete summary. In addition, the
DAVID

(Database

for

Annotation,

Visualization

and

Integrated

Discovery)

bioinformatics resource (Huang et al., 2009a, b) identified ion channel activity
(1.07×10-5), cell adhesion (9.76×10-5) and transmission of nerve impulse (5.37×10-4) to be
the top enriched functional clusters, as highlighted in Table 8.6d. The identified pathways
remained highly stable when the number of top contributing SNPs was adjusted from
1,000 to 5,000, as shown in Table 8.7.

Figure 8.5: Number of top contributing SNPs. The blue curve shows the plot of
descending normalized component weights; L1 and L2 represent the linear fits to the two
segments of the component curve; A denotes the intersection of L1 and L2; L3 represents
the line connecting the origin and the intersection A; B denotes the intersection of L3 and
the component curve.
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Figure 8.6: Manhattan plot for the identified SNP component.
Table 8.6: Pathway analyses.
a. IPA neurological disease

Genes

P-value

P-value (B-H)

ALG9,CA10,CACNA1G,CMTM8,DLAT,FLJ35024,
GABRG3,GRID1,GRIN2A,GRM5,HTR4,ME1,MRPL48,
NCAM1,PRKCA,PRKCB,SYN3,THRB,TRPM2
Pervasive developmental disorder AUTS2,CNTNAP2,GNA14,GRIN2A,MBD5,NLGN1
Schizophrenia
ACSBG1,CACNA1G,CACNG2,CNTNAP2,DPYD,
GABRG3,GRID1,GRIN2A,GRM5,GRM7,NCAM1,
NELL1,NELL2,PRKCB,RBFOX1,ROBO1,RTN4,SHANK3,
SND1,ST8SIA2,SYN3,TEKT5,TMTC1,UHMK1,ZFHX3
Partial seizure
CACNA1G,CACNA2D3,GABRG3,GABRR3,GRIN2A,KCNQ5
Autosomal dominant mental
CACNG2,KIF1A,MBD5
retardation
Complex partial seizure
CACNA1G,CACNA2D3,GABRG3,GABRR3
Localization-related epilepsy
CACNA1G,CACNA2D3,CNTNAP2,GABRG3,GABRR3
Epilepsy
CACNA1G,CACNA2D3,CH25H,CNTNAP2,GABRG3,GABRR3,
GRIN2A,KCNQ5,KCTD7,ME2,STXBP1,TMTC1,TRIB1
Absence seizure
CACNA1G,GABRG3,GABRR3
Major depression
CEP68,GABRG3,GRIN2A,GRM5,ITIH4,KCNK2,NCAM1,
RCAN1,RSU1

7.56E-04

1.75E-01

3.49E-03
5.50E-03

1.75E-01
1.75E-01

9.86E-03
1.08E-02

1.75E-01
1.75E-01

1.51E-02
1.69E-02
2.79E-02

1.75E-01
1.75E-01
2.03E-01

4.14E-02
4.37E-02

2.34E-01
2.34E-01

b. IPA nervous system
development and function

Genes

P-value

P-value (B-H)

Neuritogenesis
Formation of neurites
Formation of dendrites
Cell-cell adhesion of neurons
Axonogenesis

CAMK1D,CNTN4,DCC,LRRC4C,MARCO,NCAM1,RAC1
CAMK1D,MARCO,RAC1,ROBO1
CAMK1D,MARCO,RAC1
CNTN4,NLGN1
CNTN4,DCC,LRRC4C

2.81E-04
1.55E-03
2.39E-03
5.21E-03
5.68E-03

9.88E-02
1.75E-01
1.75E-01
1.75E-01
1.75E-01

c. IPA canonical pathway

Genes

P-value

P-value (B-H)

1.70E-05

5.50E-03

6.31E-04

1.02E-01

2.24E-03

2.08E-01

Bipolar disorder

Synaptic Long Term Depression GNA14,ITPR1,GRM5,GRM7,GNAI3,GRID1,PLB1,
RYR3,LYN,GNAT2,PPP2R1B,PRKCB,PRKCA
CREB Signaling in Neurons
GRM5,GRM7,GNAI3,GRIN2A,GRID1,GNAT2,
PIK3CD,GNA14,ITPR1,CREB5,PRKCA,PRKCB
Neuropathic Pain Signaling In GRM5,GRM7,GRIN2A,CAMK1D,PIK3CD,ITPR1,
Dorsal Horn Neurons
PRKCA,PRKCB
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CXCR4 Signaling

GNAI3,RAC1,LYN,GNAT2,PIK3CD,GNA14,ITPR1,
ELMO1,PRKCA,PRKCB
AP2M1,ITSN1,RAC1,PIK3CD,AP1B1,PRKCA,PRKCB

2.95E-03

2.08E-01

4.90E-03

2.08E-01

LRRC4C,ITSN1,KALRN,RAC1,GNA14,ROBO1,
ADAMTS2,GNAI3,SRGAP3,NTRK3,DCC,ADAM19,RTN4,
ADAM23,GNAT2,PIK3CD,WNT5B,PRKCA,PRKCB
AADAC,EXT1,EXTL2,HS3ST4,CHST15

5.13E-03

2.08E-01

5.13E-03

2.08E-01

GNAI3,CAMK1D,RAC1,UHMK1,PIK3CD,ARHGEF3,
ITPR1,E2F3,PPP2R1B,PRKCA,PRKCB
GRM5,GRM7,GRIN2A,GNA14,ITPR1,CREB5,PRKCA,
PRKCB
GNAI3,KALRN,ITSN1,RAC1,GNAT2,GNA14
AADAC,EXT1,EXTL2,HS3ST4,CHST15
GNAI3,RAC1,GNA14,ITPR1,CREB5,NFKB1,PRKCA,
PRKCB
PTPN7,PTPRD,PTPN3,ITPR1,NFKB1,CREB5,PDE1C,
GNAI3,HHAT,ADD3,RYR3,DCC,PTPRS,PDE8B,
PRKCB,PRKCA
GNAI3,CAMK1D,GNAT2,PIK3CD,ARHGEF3,
GNA14,ITPR1,NFKB1,PRKCA,PRKCB
GNAI3,RAC1,PIK3CD,ITPR1,NFKB1,PRKCA,PRKCB
TRAF6,RPS6KA2,CREB5,NFKB1

5.25E-03

2.08E-01

5.89E-03

2.11E-01

7.24E-03
9.12E-03
1.00E-02

2.30E-01
2.65E-01
2.68E-01

1.26E-02

2.74E-01

1.29E-02

2.74E-01

fMLP Signaling in Neutrophils
Role of IL-17F in Allergic
Inflammatory Airway Diseases
G-Protein Coupled Receptor
GRM5,GRM7,GNAI3,HTR4,PDE8B,PIK3CD,
Signaling
GNA14,CREB5,NFKB1,PDE1C,PRKCA,PRKCB
Role of NFAT in Regulation of the RCAN1,GNAI3,LYN,GNAT2,PIK3CD,GNA14,
Immune Response
ITPR1,NFKB1,LCP2
Endothelin-1 Signaling
GNAI3,PLB1,GNAT2,EDNRA,PIK3CD,GNA14,
ITPR1,PRKCA,PRKCB
GABA Receptor Signaling
GABRG3,GABRR3,AP2M1,AP1B1
Nitric Oxide Signaling in the
CACNA1E,PIK3CD,ITPR1,PDE1C,PRKCA,PRKCB
Cardiovascular System
LPS-stimulated MAPK Signaling RAC1,PIK3CD,NFKB1,PRKCA,PRKCB
Tec Kinase Signaling
GNAI3,LYN,GNAT2,PIK3CD,GNA14,NFKB1,
PRKCA,PRKCB
Dopamine-DARPP32 Feedback GNAI3,GRIN2A,CACNA1E,ITPR1,CREB5,
in cAMP Signaling
PPP2R1B,PRKCA,PRKCB
Role of p14/p19ARF in Tumor
RAC1,PIK3CD,NPM2
Suppression
Relaxin Signaling
GNAI3,GNAT2,PDE8B,PIK3CD,GNA14,NFKB1,PDE1C
NGF Signaling
TRAF6,RAC1,PIK3CD,RPS6KA2,CREB5,NFKB1
Role of Tissue Factor in Cancer RAC1,LYN,PIK3CD,GNA14,RPS6KA2,PRKCA
Renin-Angiotensin Signaling
RAC1,PIK3CD,ITPR1,NFKB1,PRKCA,PRKCB
Glutamate Receptor Signaling GRM5,GRM7,GRIN2A,GRID1
Fc Epsilon RI Signaling
RAC1,LYN,PIK3CD,LCP2,PRKCA,PRKCB
Androgen Signaling
GNAI3,GNAT2,GNA14,NFKB1,PRKCA,PRKCB
FGF Signaling
RAC1,PIK3CD,ITPR1,CREB5,PRKCA

1.29E-02
1.51E-02

2.74E-01
2.85E-01

1.66E-02

2.85E-01

1.70E-02

2.85E-01

1.70E-02

2.85E-01

2.24E-02
2.40E-02

3.56E-01
3.66E-01

2.82E-02
2.88E-02

3.94E-01
3.94E-01

3.16E-02

3.94E-01

3.24E-02

3.94E-01

3.55E-02
3.80E-02
3.98E-02
4.17E-02
4.17E-02
4.27E-02
4.47E-02
4.90E-02

3.94E-01
3.94E-01
3.94E-01
3.94E-01
3.94E-01
3.94E-01
3.94E-01
3.94E-01

d. DAVID functional annotation Genes

P-value

P-value (B-H)

Virus Entry via Endocytic
Pathways
Axonal Guidance Signaling

Heparan Sulfate Biosynthesis
(Late Stages)
Breast Cancer Regulation by
Stathmin1
Synaptic Long Term
Potentiation
Ephrin B Signaling
Heparan Sulfate Biosynthesis
GNRH Signaling
Protein Kinase A Signaling

Thrombin Signaling

Ion channel activity

Cell adhesion

Transmission of nerve impulse

KCNK17,GABRG3,KCND3,NOX5,GRIN2A,CACNG2,
1.07E-05
CACNA2D3,KCNIP1, KCNK2, ITPR1, KCNIP4,
TRPM2,KCTD7,GABRR3,ACCN1,KCNQ5,KCNK9,RYR3,
GRM7,CACNA1G,ABCC4,CACNA1E,NALCN,GRID1
PPFIA2,MPZL2,MYBPC2,PKHD1,GNE,NELL1,NELL2,
9.76E-05
CTNND2,EDIL3,ITGBL1,ROBO1,RAC1,CNTNAP2,
COL12A1,CD6,FLRT2,SELP,HAPLN1,GMDS,CNTNAP4,
ADAM23,NLGN1,STXBP1,PTPRS,AJAP1,CTNNA3,
CDH12,NCAM1,SIGLEC1,SNED1,CNTN4,NTM
PRKCA,GABRG3,GRIN2A,NLGN1,CACNG2,KCNIP1,
5.37E-04
ACSBG1,GRM5,HCRTR2,ACCN1,KCNQ5,GABRR3,
CBLN1.GRM7,SYN3,SLC22A3,CNTNAP2,CACNA1E,UNC13C
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Table 8.7: IPA canonical pathways with varying numbers of top contributing SNPs.
IPA canonical
pathway

N = 1000

N = 2000

N = 3000

N = 4000

N = 5000

p/p (B-H)

p/p (B-H)

p/p (B-H)

p/p (B-H)

p/p (B-H)

Synaptic Long Term 5.62E-03/7.29E-01 7.24E-05/2.34E-02 2.04E-05/7.08E-03 3.55E-04/1.37E-01 1.86E-3/1.87E-01
Depression
ITPR1,GNA14,GRM5,GRM7,GNAI3,GRID1,PLB1,PLCG2,RYR3,LYN,IGF1R,
GNAT2,PPP2R1B,PRKCB,PRKCA
CREB Signaling in
1.62E-02/7.29E-01 2.00E-03/2.28E-01 2.51E-03/2.93E-01 1.35E-03/1.95E-01 2.82E-03/1.89E-01
Neurons
GRIN2A,ITPR1,GNA14,CREB5,GRM5,GRM7,GNAI3,GRID1,
PLCG2,CREB1,PRKAG2,GNAT2,PIK3CD,GRIK1,ATM,PRKCA,PRKCB
Protein Kinase A
Signaling

1.29E-02/7.29E-01

1.17E-02/3.59E-01

5.50E-03/2.93E-01

2.40E-02/4.65E-01 6.46E-04/1.31E-01

FLNB,SMAD3,NFKB1,TGFBR2,HHAT,RYR3,CREB1,DCC,TGFB2,PTPRT,EYA2,PRKCA,PTPN7,
PTPRG,PTPRD,PTPN3,TCF7L1,PDE4B,ITPR1,PDE4D,CREB5,PDE1C,GNAI3,ADD3,PLCG2,PDE1B,
PTPRS,PRKAG2,PDE8B,SIRPA,PRKCB,AKAP1
GABA Receptor
Signaling

1.74E-02/7.29E-01

2.19E-02/4.42E-01

5.50E-02/4.73E-01

2.29E-03/1.95E-01 4.68E-05/1.91E-02

GABRG3,GABBR2,GABRR3,AP2M1,UBQLN1,GAD1,GABRB1,AP1B1,GPHN,GABRB2
Synaptic Long Term 1.62E-01/7.97E-01 1.86E-02/4.42E-01 1.05E-02/3.61E-01 1.86E-02/4.65E-01 2.19E-02/4.88E-01
Potentiation
GRM5,GRM7,GRIN2A,PLCG2,CREB1,PRKAG2,GNA14,ITPR1,CREB5,PRKCA,PRKCB

Note: N represents the number of top contributing SNPs; p and p(B-H) represent the uncorrected and
Benjamini-Hochberg corrected p-values of enrichment.

We further performed a regression analysis between the fMRI and SNP loadings with
additional controlling variables of associated behavioral assessments, as shown in (8.1).
The SNP component still showed a significant regression effect (p = 8.37×10-11) on the
fMRI component when controlling for CD-count, AUDIT-4 and ICS-fc.
-

(8.1)

8. 4

Discussion

One fMRI-SNP component pair was identified presenting a significant association (r
= -0.38, p = 3.98×10-12). Both the genetic and fMRI components were found to be
associated with clinical measures of alcohol dependence (fMRI versus CD-count: p =
7.04×10-06 and SNP versus AUDIT-4: p = 1.57×10-04). The fMRI-SNP association was
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not due to age, sex or race/ethnicity, and it was beyond the shared variance of behavioral
assessments, as confirmed with the partial correction and regression analysis. The genetic
component was elicited by a reference comprising three SNP sets derived from the
CREB-BDNF pathway. Parallel ICA with multiple references detected that the three
referential sets contributed to the same genetic component, suggesting convergent
functional influence on neurobiological conditions. The linked fMRI component reflected
regional hyperactivation for more severe alcohol dependence. Overall, the results suggest
that the CREB-BDNF pathway plays a key role in the genetic factor underlying a
proportion of variation in cue-elicited brain activations, which might play a role in
phenotypic symptoms of alcohol dependence.
fMRI component: The loadings associated with the fMRI component exhibits a
positive correlation with CD-count while the highlighted voxels present positive
component weights, indicating that subjects experiencing more severe alcohol
dependence symptoms have higher regional activations when exposed to the taste of
alcohol. The hyperactivated region majorly comprises precuneus, superior parietal lobule
(SPL) and posterior cingulate cortex (PCC), as listed in Table 8.5. Precuneus belongs to
associative cortices and is known to be directly involved in a wide spectrum of highly
integrated tasks, including episodic memory retrieval (Addis et al., 2004; Lundstrom et
al., 2005), self-referential processes (den Ouden et al., 2005; Ochsner et al., 2004) and
consciousness (Laureys et al., 2004). Also, precuneus may subserve a variety of
functional processes given its wide-spread connections with both adjacent areas such as
PCC and SPL, and frontal lobes including prefrontal cortex and anterior cingulate cortex
(Cavanna and Trimble, 2006). Although not generally targeted for addiction, precuneus
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and adjacent parietal regions have been robustly implicated in craving studies, where
hyperactivation elicited by drug-related cues are found relating to severity of dependence
(Claus et al., 2011; Liu et al., 2013; Park et al., 2007; Tapert et al., 2004; Yalachkov et
al., 2010). PCC is suggested as functioning to rapidly associate particularly familiar
sensory stimuli (Buccino et al., 2001) and frequently implicated in the processing of
drug-related stimuli (Garavan et al., 2000; Kosten et al., 2006; Tapert et al., 2004; Wrase
et al., 2007). In particular, there is evidence that increased activation to cocaine cues in
PCC is associated with relapse to cocaine abuse (Kosten et al., 2006). Of particular
interest, as implicated in a meta-analysis on fMRI studies of alcohol cue reactivity, brain
activation in precuneus and PCC, instead of the mesolimbic system, most effectively
differentiates cases from controls in terms of alcohol use severity (Schacht et al., 2013).
Overall, the identified brain network echoes considerable similar findings and deserves
more attention to elucidate the neuropathology of addiction.
SNP component: The linked SNP component exhibits a negative correlation with the
fMRI component and behavioral assessment, indicating that subjects carrying lower
loadings on the SNP component present higher brain activation in the identified
precuneus region. Top 2,020 SNPs are selected out as predominantly contributing to the
identified component, among which 1,019 reside in 457 unique genes. Pathway analyses
delineate a complex genetic architecture emphasizing synaptic plasticity and other neural
signaling pathways. Considering that a meta-analysis identified 3,800 genes differentially
expressed between models of high and low amounts alcohol consumption (Mulligan et al.,
2006), our finding highlights one side of the story where CREB serves as a convergence
point of various neurocircuitries related to alcohol dependence.
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CREB signaling: Given that the reference is derived from CREB and BDNF genes,
it’s not surprising that the related pathway is enriched in the finding. cAMP-response
element-binding protein (CREB) functions as a transcription factor and is well known for
its role in neuronal plasticity and long-term memory (Carlezon et al., 2005; Lonze and
Ginty, 2002; Silva et al., 1998). Brain derived neurotrophic factor (BDNF) is a CREB
regulated gene that also plays an important role in synaptic plasticity (Bramham and
Messaoudi, 2005; Mattson et al., 2004). While drug addiction might be partly considered
as a result of adaptations in specific brain neurons due to repeated exposure to a
substance of abuse, there is considerable evidence that learning/memory and addiction
converge in a variety of aspects, one of which being that both are modulated by
transcription factor CREB and neurotrophic factors (Bolanos and Nestler, 2004; Nestler,
2002, 2005; Pandey et al., 2005; Pierce and Bari, 2001). In particular, one SNP in BDNF
(rs6265_A or Val66Met, ‘A’ represents the minor allele) has been identified as predicting
relapse in alcohol dependence patients, where minor allele carriers show decreased
vulnerability to relapse (Wojnar et al., 2009). This is consistent with our finding where
the same SNP exhibits a positive weight, indicating that minor allele carriers exhibit
lower brain activation which is associated with less severe alcohol dependence.
Synaptic LTD and LTP: Synaptic LTP and LTD are two forms of synaptic plasticity
which enhances or weakens, respectively, the synchronized stimulations between neurons,
thus allowing the refinement of neuronal circuits underlying learning and memory
(Malenka and Bear, 2004). It’s commonly recognized that synaptic plasticity plays an
important role in the development of addiction, through which use of drug progresses
from impulsive to compulsive behavior (Kauer and Malenka, 2007; Mameli and Luscher,
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2011; Nestler, 2001). Genetic variations may also account for a proportion of variation in
synaptic plasticity. As revealed by a meta-analysis, LTD and LTP are among the top
enriched pathways for the 396 addiction-related genes implicated in two or more
independent studies (Li et al., 2008). In our finding, the synaptic LTD and LTP pathways
strongly overlap with the CREB signaling pathway, highlighting metabotropic glutamate
receptors (GRM5 and GRM7) and ionotropic glutamate receptors (GRID1 and GRIN2A),
as well as protein kinase C (PRKCA and PRKCB). The SNP in GRIN2A (rs4628972_G)
and three SNPs in PRKCA (rs17688881_C, rs721429_A and rs7217618_C) present
negative weights, indicating that the minor allele carriers show high brain activation and
more severe alcohol dependence. The opposite is observed for the rest (rs1000061_G in
GRM5, rs1353832_C in GRM7, rs1863824_C in GRID1, rs8077110_T in PRKCA and
rs880824_A in PRKCB) which all present positive weights.
Protein kinase A signaling (PKA): The cAMP-PKA pathway is a primary signaling
cascade that modulates numerous cellular events in neurons, including synaptic plasticity
(Abel and Kandel, 1998; Skalhegg and Tasken, 2000; Waltereit and Weller, 2003). It’s
documented that all drugs of abuse alter cAMP-PKA signaling and activation of the
cAMP-PKA pathway leads to increased activity of the transcription factor CREB (Ron
and Jurd, 2005). Direct evidence is also provided that genetic mutation reducing
cAMP-PKA signaling results in increased sensitivity to the sedative effects of ethanol
(Wand et al., 2001). In our finding, a number of genes are involved in this pathway, 4 of
which encode protein tyrosine phosphatase (PTPN3, PTPN7, PTPRD and PTPRS),
known to be signaling molecules regulating a variety of cellular processes including cell
growth and differentiation (Denhertog et al., 1993). Specifically, both two SNPs in
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PTPN3 (rs10979861_C and rs7046039_T) exhibit negative weights while the rest
(rs10920336_C in PTPN7, rs10815927_C and rs10756029_C in PTPRD, and
rs1015675_A in PTPRS) contribute with positive weights.
GABA receptor signaling: As a major inhibitory neurotransmitter in the central
nervous system, GABAergic signaling has been implicated in addiction in numerous
studies (Kauer and Malenka, 2007; Pandey, 1998). It’s reported that chronic cocaine uses
decrease GABAergic synapse function, such that LTP induction is not effectively
suppressed at excitatory synapses, which is believed to increase the likelihood of firing to
a stimulus (Liu et al., 2005). Polymorphisms in GABA receptors are consistently
identified as susceptibility loci to addiction in genome-wide association studies (Bierut et
al., 2010; Enoch et al., 2009; Radel et al., 2005). In particular, a number of SNPs in
GABRG3 are shown to be associated with alcohol dependence (Dick et al., 2004). In our
finding, all the three identified SNPs in GABRG3 (rs12439549_G, rs4438262_G and
rs3922613_G) contribute with positive weights. Regarding GABRR3, two SNPs
(rs1874864_G and rs7638369_T) present positive weights while the rest (rs1844934_T,
rs1688378_A and rs1492054_C) exhibit negative weights. Although not targeted as
references, these two genes deserve more attention in future investigations.
The identified genetic component is not specific to alcohol use disorders. As
suggested by IPA, the genes harboring top contributing SNPs are overrepresented for
other neurobiological diseases, including bipolar disorder, schizophrenia and major
depression. This suggests a genetic basis for the comorbidity among these disorders, for
which accumulated evidence has been provided (Johnson et al., 2009; Kendler et al.,
2003; Purcell et al., 2009a). The genetic component also captures neurodevelopmental
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functions such as neuritogenesis and cell adhesion, which conforms with the notion that
adolescent cortical development is a critical period of vulnerability for both addiction
(Crews et al., 2007) and schizophrenia (Rapoport et al., 2012). On the other hand, it
needs to be emphasized that the genetic component is more tightly associated with the
imaging component, explaining a relatively large amount of variance in the observed
alterations in brain activation. As the fMRI-SNP association is not majorly due to the
shared relationship with alcohol dependence, the observed variation of brain function is
partly regulated by the genetic variations. The remainder variances might be due to other
genetic or environmental factors or their interactions which awaits further investigations.
In summary, our finding confirms the genetic variation induced vulnerability to
disruptions in brain function which might play a role in alcohol dependence. The
identified genetic component reflects polygenicity and heterogeneity, involving a variety
of synaptic plasticity and neural signaling pathways implicated in a wide spectrum of
disorders including addiction. Association analyses reveal that this complex genetic
factor strongly affects neurobiological conditions, contributing to altered cue-elicited
brain activations in precuneus. While the identified brain network is known to participate
in many cognitive processes and robustly implicated in craving-related studies, our work
emphasizes the genetic underpinnings and highlights a key role of the CREB-BDNF
pathway.
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CHAPTER 9

CONCLUSIONS AND FUTURE WORK

In summary, our work makes several important contributions to advance the
application of ICA to imaging genetics studies. First, as presented in Chapter 3, we
designed a consistency-based order estimation approach to locate the order range which
allows ICA to extract relatively accurate, consistent components and loadings for
genotype data. Subsequently, to assist the decomposition of high-dimensional data, we
developed a semi-blind multivariate model, pICA-R, as presented in Chapter 4. The new
approach assesses many variables for aggregate effects while incorporating prior
knowledge. It helps pinpoint a particular component of interest embedded in a large
complex dataset, thus improving the robustness of the results. Guided by a single
referential SNP set derived from ANK3, pICA-R identified a significant sMRI-SNP
association, revealing a complex genetic component underlying the SZ-related gray
matter concentration reduction in frontal and temporal regions. In Chapter 5, we further
extended pICA-R to accommodate multiple referential SNP sets whose interrelationship
is unknown. The extended model enables robust investigations on potentially related
genetic variants implicated in molecular, cellular or system biology. When the extended
parallel ICA with multiple references was employed to study the genetic influence on
alcohol dependence, three referential SNP sets derived from the CREB-BDNF pathway
were identified as contributing to the same SNP component significantly linked to altered
regional brain activation. The results strongly suggest that the CREB-BDNF pathway
functions as a convergence point of various synaptic and neural signaling processes
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underlying the variation in cue-elicited brain activations in precuneus, which might be
involved in phenotypic symptoms of alcohol dependence.
There are still many aspects to be explored in the future regarding the application of
ICA in the imaging genetics field. For instance, from the method’s point of view, a
regularization of sparsity can be introduced to further improve the robustness of the
model in high-dimensional space. The assumption is that when millions of genetic
variants are included in a model as potential causal loci, it’s more likely that most of
them do not contribute significantly to the trait of interest. Consequently, the underlying
component (or source) is expected to be sparse. Sparsity-regularized linear models have
been used for model selection in the context of genome wide association (Cantor et al.,
2010; Vounou et al., 2010; Wu et al., 2009), however yet investigated in commonly used
ICA frameworks. On the other hand, it would also be interesting to investigate the genetic
factors underlying neurobiological traits captured with other imaging modalities, such as
functional network connectivity in resting-state fMRI and tractography in diffusion tensor
imaging. For instance, it has been widely acknowledged that SZ patients tend to have less
integrated, more diverse profiles of brain functional connectivity (Lynall et al., 2010).
This is at least partly due to deficits in white matter tracts which result in a disconnected
configuration of gray matter regions (Bassett et al., 2008; Zhou et al., 2008).
Investigation on the genetic underpinnings is expected to further improve our
understanding of the biological mechanisms underlying the disorder.
Some of the works in this dissertation have been published. The consistency-based
order estimation approach appears in (Chen et al., 2012a); the preliminary investigation
of guided exploration of genomic risk for SZ is in (Chen et al., 2012c) and the pICA-R
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approach appears in (Chen et al., 2013). A manuscript is ready for submission for the
exploration of scanning effects and another manuscript is under preparation for the
extended parallel ICA with multiple references and its application to alcohol dependence.
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